Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways
Variants search result for All species
(View Results for all Objects and Ontologies)


921 records found for search term Map2k2
Refine Term:
Sort By:
           Export CSV TAB Print

RGD IDSymbolVariant TypeNameTraitClinical SignificanceChrStartStopSpeciesAnnotationsMatch
12846289CV376554single nucleotide variantNM_030662.4(MAP2K2):c.*2A>Tnot specified [RCV000441365]likely benign1940905964090596Humanname
12835047CV377543single nucleotide variantNM_030662.4(MAP2K2):c.-9G>Anot provided [RCV000421011]|not specified [RCV004701478]likely benign|uncertain significance1941238844123884Humanname
13527540CV506841single nucleotide variantNM_030662.4(MAP2K2):c.-4C>GCardiovascular phenotype [RCV004025003]|not provided [RCV001719091]|not specified [RCV003987621]likely benign|uncertain significance1941238794123879Humanname
8609081CV55387single nucleotide variantNM_030662.3(MAP2K2):c.*8C>TNoonan syndrome and Noonan-related syndrome [RCV001813363]|RASopathy [RCV000523941]|not specified [RCV000039466]benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance1940905904090590Human1name
8609082CV55389single nucleotide variantNM_030662.4(MAP2K2):c.*9G>Anot specified [RCV000039467]likely benign1940905894090589Humanname
150450425CV1215245single nucleotide variantNM_030662.4(MAP2K2):c.*24C>Gnot provided [RCV001611835]benign1940905744090574Humanname
8691901CV141867single nucleotide variantNM_030662.3(MAP2K2):c.*19C>Tnot provided [RCV001723694]|not specified [RCV000126682]benign|likely benign1940905794090579Humanname
155741371CV1779973single nucleotide variantNM_030662.4(MAP2K2):c.-16G>Anot specified [RCV002302577]uncertain significance1941238914123891Humanname
11637876CV264853single nucleotide variantNM_030662.4(MAP2K2):c.-42C>Tnot provided [RCV000293798]likely benign|uncertain significance1941239174123917Humanname
12834714CV377714single nucleotide variantNM_030662.4(MAP2K2):c.-23C>Anot provided [RCV000420421]likely benign1941238984123898Humanname
12835337CV377716single nucleotide variantNM_030662.4(MAP2K2):c.-47A>Gnot provided [RCV000421494]likely benign1941239224123922Humanname
12833891CV379588single nucleotide variantNM_030662.4(MAP2K2):c.*20G>Anot provided [RCV001704470]|not specified [RCV000419366]benign|likely benign1940905784090578Humanname
12837593CV379589single nucleotide variantNM_030662.4(MAP2K2):c.*14C>Tnot specified [RCV000425437]likely benign1940905844090584Humanname
11542335CV49318single nucleotide variantNM_030662.4(MAP2K2):c.*24C>Tnot provided [RCV001636616]|not specified [RCV000248903]benign1940905744090574Humanname
13526102CV507414single nucleotide variantNM_030662.4(MAP2K2):c.-50C>Anot specified [RCV000603670]likely benign1941239254123925Humanname
151352088CV1325066single nucleotide variantNM_030662.4(MAP2K2):c.-243C>TNoonan syndrome and Noonan-related syndrome [RCV001813621]benign1941241184124118Humanname
152063609CV1587855single nucleotide variantNM_030662.4(MAP2K2):c.93-4G>TRASopathy [RCV002090571]likely benign1941176334117633Human1name
9690498CV176033single nucleotide variantNM_030662.4(MAP2K2):c.93-6C>TNoonan syndrome and Noonan-related syndrome [RCV001813405]|RASopathy [RCV000465734]|not provided [RCV001711316]|not specified [RCV000156178]likely benign|conflicting interpretations of pathogenicity|uncertain significance1941176354117635Human1name
156006500CV1902735single nucleotide variantNM_030662.4(MAP2K2):c.93-8C>TRASopathy [RCV003099055]likely benign1941176374117637Human1name
597893586CV3857104single nucleotide variantNM_030662.4(MAP2K2):c.92+8G>ARASopathy [RCV005200967]likely benign1941237764123776Human1name
150502609CV49319single nucleotide variantNM_030662.4(MAP2K2):c.*174C>Anot provided [RCV001595149]benign1940904244090424Human4name
13796619CV553046single nucleotide variantNM_030662.4(MAP2K2):c.-206G>Tnot provided [RCV000680668]benign1941240814124081Humanname
13796560CV553047single nucleotide variantNM_030662.3(MAP2K2):c.-269G>Anot provided [RCV000680647]benign1941241444124144Humanname
13796618CV553048single nucleotide variantNM_030662.3(MAP2K2):c.-285G>Tnot provided [RCV000680667]benign1941241604124160Humanname
13796731CV553049single nucleotide variantNM_030662.3(MAP2K2):c.-366G>Anot provided [RCV000680725]benign1941242414124241Humanname
13797739CV553050single nucleotide variantNM_030662.3(MAP2K2):c.-406C>Anot provided [RCV000681396]likely benign1941242814124281Humanname
13797738CV553051single nucleotide variantNM_030662.3(MAP2K2):c.-419C>Anot provided [RCV000681395]likely benign1941242944124294Humanname
127245463CV1106528single nucleotide variantNM_030662.4(MAP2K2):c.528+7C>TRASopathy [RCV001424323]likely benign1941023694102369Human1name
127290813CV1127904single nucleotide variantNM_030662.4(MAP2K2):c.984+8C>TRASopathy [RCV001475872]likely benign1940972714097271Human1name
127294515CV1158549duplicationNM_030662.4(MAP2K2):c.93-15dupNoonan syndrome and Noonan-related syndrome [RCV001813600]|RASopathy [RCV001511778]benign|uncertain significance1941176384117639Human1name
150508667CV1214102single nucleotide variantNM_030662.4(MAP2K2):c.581-3C>TRASopathy [RCV001866247]|not provided [RCV001596623]likely benign|uncertain significance1941011464101146Human1name
150479624CV1239417single nucleotide variantNM_030662.4(MAP2K2):c.92+27C>Gnot provided [RCV001652580]benign1941237574123757Humanname
150503090CV1241723single nucleotide variantNM_030662.4(MAP2K2):c.93-31A>Gnot provided [RCV001657314]benign1941176604117660Humanname
150492440CV1281110single nucleotide variantNM_030662.4(MAP2K2):c.93-78A>Gnot provided [RCV001716813]benign1941177074117707Humanname
151795253CV1338537single nucleotide variantNM_030662.4(MAP2K2):c.529-2A>CRASopathy [RCV001898553]uncertain significance1941012824101282Human1name
151800014CV1365727single nucleotide variantNM_030662.4(MAP2K2):c.705+2T>CRASopathy [RCV001917630]uncertain significance1941010174101017Human1name
151710472CV1376960single nucleotide variantNM_030662.4(MAP2K2):c.528+6T>CRASopathy [RCV001889269]uncertain significance1941023704102370Human1name
8691902CV141868single nucleotide variantNM_030662.4(MAP2K2):c.93-20A>CCardiofaciocutaneous syndrome 4 [RCV005229950]|RASopathy [RCV002055668]|not provided [RCV004717044]|not specified [RCV000126683]benign1941176494117649Human2name
152083884CV1533357single nucleotide variantNM_030662.4(MAP2K2):c.920-6G>AMAP2K2-related disorder [RCV003968850]|RASopathy [RCV002093211]likely benign1940973494097349Human2name , trait , alternate_id
152171496CV1552770single nucleotide variantNM_030662.4(MAP2K2):c.93-11G>TRASopathy [RCV002143466]likely benign1941176404117640Human1name
152142108CV1583636single nucleotide variantNM_030662.4(MAP2K2):c.705+8C>GRASopathy [RCV002120514]likely benign1941010114101011Human1name
152150836CV1605450single nucleotide variantNM_030662.4(MAP2K2):c.92+12G>TRASopathy [RCV002102205]likely benign1941237724123772Human1name
152083720CV1647933single nucleotide variantNM_030662.4(MAP2K2):c.450+9G>TRASopathy [RCV002076711]likely benign1941105004110500Human1name
9689189CV176032single nucleotide variantNM_030662.4(MAP2K2):c.303+8C>GMAP2K2-related disorder [RCV003945213]|RASopathy [RCV000520093]|not provided [RCV000587724]|not specified [RCV000154642]benign1941174114117411Human2name , trait , alternate_id
156346227CV1868340single nucleotide variantNM_030662.4(MAP2K2):c.581-2A>GRASopathy [RCV003064534]uncertain significance1941011454101145Human1name
156371480CV1923592single nucleotide variantNM_030662.4(MAP2K2):c.580+5G>CRASopathy [RCV002633424]uncertain significance1941012244101224Human1name
156406292CV1963556single nucleotide variantNM_030662.4(MAP2K2):c.451-6C>GRASopathy [RCV002585858]likely benign|uncertain significance1941024594102459Human1name
156314322CV2031792single nucleotide variantNM_030662.4(MAP2K2):c.581-4C>GRASopathy [RCV002716713]likely benign1941011474101147Human1name
156015735CV2035076single nucleotide variantNM_030662.4(MAP2K2):c.581-8G>TRASopathy [RCV002780393]likely benign1941011514101151Human1name
156118172CV2035708single nucleotide variantNM_030662.4(MAP2K2):c.580+8C>TRASopathy [RCV002785679]likely benign1941012214101221Human1name
156228267CV2088906single nucleotide variantNM_030662.4(MAP2K2):c.93-10G>CRASopathy [RCV002876136]likely benign1941176394117639Human1name
156188680CV2098893single nucleotide variantNM_030662.4(MAP2K2):c.985-5C>GRASopathy [RCV002917375]likely benign1940954544095454Human1name
156134414CV2109399single nucleotide variantNM_030662.4(MAP2K2):c.529-7C>GRASopathy [RCV002914671]uncertain significance1941012874101287Human1name
156028488CV2125303single nucleotide variantNM_030662.4(MAP2K2):c.919+9T>GRASopathy [RCV002949119]likely benign1940991924099192Human1name
156366305CV2130669single nucleotide variantNM_030662.4(MAP2K2):c.93-10G>TRASopathy [RCV002967333]likely benign1941176394117639Human1name
156328653CV2216238single nucleotide variantNM_030662.4(MAP2K2):c.450+5G>ACardiovascular phenotype [RCV004097198]|RASopathy [RCV003539463]uncertain significance1941105044110504Human1name
11090941CV231025single nucleotide variantNM_030662.4(MAP2K2):c.581-8G>ACardiofaciocutaneous syndrome 4 [RCV003741165]|RASopathy [RCV001442552]|not provided [RCV001722158]|not specified [RCV000216682]benign|likely benign1941011514101151Human2name
11546944CV257129single nucleotide variantNM_030662.4(MAP2K2):c.529-5T>CRASopathy [RCV001487659]|not specified [RCV000247121]likely benign|uncertain significance1941012854101285Human1name
11642738CV265077single nucleotide variantNM_030662.4(MAP2K2):c.580+5G>Anot provided [RCV000380904]uncertain significance1941012244101224Humanname
401908242CV2815195duplicationNM_030662.4(MAP2K2):c.528+1dupnot provided [RCV003423209]uncertain significance1941023744102375Humanname
405160065CV2868114deletionNM_030662.4(MAP2K2):c.93-20delRASopathy [RCV003539643]likely benign1941176494117649Human1name
405162375CV2869201single nucleotide variantNM_030662.4(MAP2K2):c.706-9C>GRASopathy [RCV003539686]likely benign1940994234099423Human1name
405159197CV2870384single nucleotide variantNM_030662.4(MAP2K2):c.920-8C>GRASopathy [RCV003539605]likely benign1940973514097351Human1name
405161340CV2890764single nucleotide variantNM_030662.4(MAP2K2):c.303+6C>TRASopathy [RCV003540141]uncertain significance1941174134117413Human1name
405162602CV2896671single nucleotide variantNM_030662.4(MAP2K2):c.919+7C>TRASopathy [RCV003540222]likely benign1940991944099194Human1name
405163602CV2911998single nucleotide variantNM_030662.4(MAP2K2):c.304-4G>ARASopathy [RCV003540241]likely benign1941106594110659Human1name
405054569CV2940480single nucleotide variantNM_030662.4(MAP2K2):c.92+18A>TRASopathy [RCV003655456]likely benign1941237664123766Human1name
405058137CV2968898single nucleotide variantNM_030662.4(MAP2K2):c.450+8C>TRASopathy [RCV003655679]likely benign1941105014110501Human1name
405060024CV2981880single nucleotide variantNM_030662.4(MAP2K2):c.451-4C>TRASopathy [RCV003655764]likely benign1941024574102457Human1name
405041137CV3141119single nucleotide variantNM_030662.4(MAP2K2):c.450+3G>ARASopathy [RCV003831412]uncertain significance1941105064110506Human1name
405236313CV3169010single nucleotide variantNM_030662.4(MAP2K2):c.92+15G>ARASopathy [RCV003866289]likely benign1941237694123769Human1name
408387281CV3518788single nucleotide variantNM_030662.4(MAP2K2):c.528+5G>Tnot provided [RCV004761107]uncertain significance1941023714102371Humanname
597662542CV3709758single nucleotide variantNM_030662.4(MAP2K2):c.304-3C>GCardiofaciocutaneous syndrome 4 [RCV005028651]uncertain significance1941106584110658Human1name
597864332CV3742131single nucleotide variantNM_030662.4(MAP2K2):c.528+7C>GRASopathy [RCV005067747]likely benign1941023694102369Human1name
597956330CV3754609single nucleotide variantNM_030662.4(MAP2K2):c.985-3C>TRASopathy [RCV005080459]uncertain significance1940954524095452Human1name
597953122CV3756661single nucleotide variantNM_030662.4(MAP2K2):c.580+3A>GRASopathy [RCV005079719]uncertain significance1941012264101226Human1name
12833474CV379594single nucleotide variantNM_030662.4(MAP2K2):c.304-7C>TRASopathy [RCV001441223]|not provided [RCV000418571]likely benign1941106624110662Human1name
597937626CV3807884single nucleotide variantNM_030662.4(MAP2K2):c.919+1G>ARASopathy [RCV005158263]uncertain significance1940992004099200Human1name
597880875CV3826445single nucleotide variantNM_030662.4(MAP2K2):c.93-15G>TRASopathy [RCV005178142]likely benign1941176444117644Human1name
597895420CV3833676single nucleotide variantNM_030662.4(MAP2K2):c.303+9T>GRASopathy [RCV005180368]likely benign1941174104117410Human1name
597940933CV3836646single nucleotide variantNM_030662.4(MAP2K2):c.93-12G>ARASopathy [RCV005187667]likely benign1941176414117641Human1name
597925898CV3855290single nucleotide variantNM_030662.4(MAP2K2):c.92+11A>GRASopathy [RCV005205889]likely benign1941237734123773Human1name
598124989CV3883762single nucleotide variantNM_030662.4(MAP2K2):c.984+5G>Anot provided [RCV005236117]uncertain significance1940972744097274Humanname
150454060CV49237single nucleotide variantNM_030662.4(MAP2K2):c.92+42G>Tnot provided [RCV001612302]benign1941237424123742Humanname
150442875CV49238single nucleotide variantNM_030662.4(MAP2K2):c.92+46G>Cnot provided [RCV001679490]benign1941237384123738Humanname
150476247CV49270single nucleotide variantNM_030662.4(MAP2K2):c.451-6C>TRASopathy [RCV003539397]|not provided [RCV001672031]benign|likely benign1941024594102459Human1name
8609103CV49278single nucleotide variantNM_030662.4(MAP2K2):c.580+6G>ACardiofaciocutaneous syndrome 4 [RCV000625449]|MAP2K2-related disorder [RCV003891460]|Noonan syndrome and Noonan-related syndrome [RCV001813314]|RASopathy [RCV000229923]|not provided [RCV000443089]|not specified [RCV000039488]benign|likely benign|conflicting interpretations of pathogenicity1941012234101223Human2name , trait , alternate_id
12845020CV49304single nucleotide variantNM_030662.4(MAP2K2):c.919+4C>TCardiofaciocutaneous syndrome 4 [RCV002496506]|RASopathy [RCV001030072]|not provided [RCV000588970]|not specified [RCV001797594]benign|likely benign|conflicting interpretations of pathogenicity1940991974099197Human2name
13529756CV507041single nucleotide variantNM_030662.4(MAP2K2):c.581-9C>TRASopathy [RCV001480416]|not specified [RCV000605856]likely benign|conflicting interpretations of pathogenicity1941011524101152Human1name
13527557CV507049single nucleotide variantNM_030662.4(MAP2K2):c.92+11A>CRASopathy [RCV002529617]|not specified [RCV000599798]likely benign1941237734123773Human1name
14690790CV621871single nucleotide variantNM_030662.4(MAP2K2):c.581-5T>CRASopathy [RCV002067381]|not specified [RCV000781518]likely benign|uncertain significance1941011484101148Human1name
15156156CV690216single nucleotide variantNM_030662.4(MAP2K2):c.451-7C>TMAP2K2-related disorder [RCV003938284]|RASopathy [RCV002064575]|not provided [RCV000868178]|not specified [RCV002307638]likely benign|uncertain significance1941024604102460Human2name , trait , alternate_id
15103906CV690217single nucleotide variantNM_030662.4(MAP2K2):c.450+9G>ANoonan syndrome and Noonan-related syndrome [RCV001813559]|RASopathy [RCV001416539]likely benign1941105004110500Human1name
34895753CV917555single nucleotide variantNM_030662.4(MAP2K2):c.919+5G>ACardio-facio-cutaneous syndrome [RCV005359914]|RASopathy [RCV005057073]|not specified [RCV001192910]uncertain significance1940991964099196Human2name
34896165CV917556single nucleotide variantNM_030662.4(MAP2K2):c.451-9G>ARASopathy [RCV005094025]|not specified [RCV001193486]likely benign|uncertain significance1941024624102462Human1name
150336134CV1165126single nucleotide variantNM_030662.4(MAP2K2):c.529-27C>Anot provided [RCV001530705]likely benign1941013074101307Humanname
150421656CV1181764single nucleotide variantNM_030662.4(MAP2K2):c.303+29G>Anot provided [RCV001552117]likely benign1941173904117390Humanname
150424059CV1185487single nucleotide variantNM_030662.4(MAP2K2):c.450+22G>Anot provided [RCV001556159]likely benign1941104874110487Humanname
150428797CV1188779single nucleotide variantNM_030662.4(MAP2K2):c.528+26C>Tnot provided [RCV001562741]likely benign1941023504102350Humanname
150407662CV1192169single nucleotide variantNM_030662.4(MAP2K2):c.304-46G>Anot provided [RCV001565081]likely benign1941107014110701Humanname
150417656CV1195415single nucleotide variantNM_030662.4(MAP2K2):c.450+40C>Tnot provided [RCV001568863]likely benign1941104694110469Humanname
150504895CV1222758single nucleotide variantNM_030662.4(MAP2K2):c.450+29C>Tnot provided [RCV001621692]benign1941104804110480Humanname
150506857CV1242316single nucleotide variantNM_030662.4(MAP2K2):c.93-242C>Anot provided [RCV001658671]benign1941178714117871Humanname
150455484CV1246922single nucleotide variantNM_030662.4(MAP2K2):c.984+33C>Tnot provided [RCV001668690]benign1940972464097246Humanname
150470500CV1258598single nucleotide variantNM_030662.4(MAP2K2):c.919+33C>Tnot provided [RCV001684143]benign1940991684099168Humanname
150480766CV1258788single nucleotide variantNM_030662.4(MAP2K2):c.303+46C>Gnot provided [RCV001685918]benign1941173734117373Humanname
150470015CV1259755single nucleotide variantNM_030662.4(MAP2K2):c.304-18G>ARASopathy [RCV001859431]|not provided [RCV001684056]benign|likely benign1941106734110673Human1name
150446248CV1261337single nucleotide variantNM_030662.4(MAP2K2):c.580+39G>Tnot provided [RCV001680011]benign1941011904101190Humanname
150477596CV1262525single nucleotide variantNM_030662.4(MAP2K2):c.451-45G>Anot provided [RCV001685338]benign1941024984102498Humanname
150475885CV1271256single nucleotide variantNM_030662.4(MAP2K2):c.529-49C>Gnot provided [RCV001696079]benign1941013294101329Humanname
150443950CV1277925single nucleotide variantNM_030662.4(MAP2K2):c.92+168A>Gnot provided [RCV001707068]benign1941236164123616Humanname
150472832CV1281296single nucleotide variantNM_030662.4(MAP2K2):c.92+204G>Anot provided [RCV001713432]benign1941235804123580Humanname
150488239CV1283977single nucleotide variantNM_030662.4(MAP2K2):c.580+31C>Tnot provided [RCV001716070]benign1941011984101198Humanname
151759275CV1340655single nucleotide variantNM_030662.4(MAP2K2):c.303+15G>TRASopathy [RCV001913788]|not specified [RCV002266059]benign|likely benign|uncertain significance1941174044117404Human1name
8691893CV141860single nucleotide variantNM_030662.4(MAP2K2):c.529-12G>ARASopathy [RCV002055665]|not specified [RCV000126672]benign|likely benign|conflicting interpretations of pathogenicity1941012924101292Human1name
8691896CV141863single nucleotide variantNM_030662.4(MAP2K2):c.705+11G>CCardiofaciocutaneous syndrome 4 [RCV003741151]|RASopathy [RCV002055666]|not provided [RCV003415934]|not specified [RCV000154752]benign1941010084101008Human2name
8691903CV141869single nucleotide variantNM_030662.4(MAP2K2):c.303+11C>TRASopathy [RCV002055669]|not specified [RCV000126684]benign1941174084117408Human1name
151866864CV1447538single nucleotide variantNM_030662.4(MAP2K2):c.919+19A>GRASopathy [RCV001924712]likely benign|uncertain significance1940991824099182Human1name
152092405CV1530894single nucleotide variantNM_030662.4(MAP2K2):c.985-19C>ACardiofaciocutaneous syndrome 4 [RCV003120830]|RASopathy [RCV002114254]|not specified [RCV003226533]likely benign|uncertain significance1940954684095468Human2name
152070644CV1535430single nucleotide variantNM_030662.4(MAP2K2):c.1046+7G>ARASopathy [RCV002111401]likely benign1940953814095381Human1name
152122414CV1554928single nucleotide variantNM_030662.4(MAP2K2):c.303+17C>TRASopathy [RCV002198235]likely benign1941174024117402Human1name
152130666CV1567755single nucleotide variantNM_030662.4(MAP2K2):c.528+19C>TRASopathy [RCV002218025]likely benign1941023574102357Human1name
152054163CV1575143single nucleotide variantNM_030662.4(MAP2K2):c.303+15G>ARASopathy [RCV002109336]likely benign1941174044117404Human1name
152107453CV1577902single nucleotide variantNM_030662.4(MAP2K2):c.985-14G>ARASopathy [RCV002096371]likely benign1940954634095463Human1name
152156027CV1589301single nucleotide variantNM_030662.4(MAP2K2):c.529-13C>TRASopathy [RCV002122437]likely benign1941012934101293Human1name
152026897CV1593602single nucleotide variantNM_030662.4(MAP2K2):c.528+17C>GRASopathy [RCV002104711]|not specified [RCV003235672]likely benign|uncertain significance1941023594102359Human1name
152172602CV1599192single nucleotide variantNM_030662.4(MAP2K2):c.304-19C>TRASopathy [RCV002143832]likely benign1941106744110674Human1name
152045376CV1600123single nucleotide variantNM_030662.4(MAP2K2):c.529-14G>TRASopathy [RCV002088490]likely benign1941012944101294Human1name
152032540CV1614813single nucleotide variantNM_030662.4(MAP2K2):c.451-19C>ARASopathy [RCV002086599]likely benign1941024724102472Human1name
152042039CV1617985single nucleotide variantNM_030662.4(MAP2K2):c.581-13C>TRASopathy [RCV002206472]likely benign1941011564101156Human1name
152047371CV1627369single nucleotide variantNM_030662.4(MAP2K2):c.451-14T>CRASopathy [RCV002108504]likely benign1941024674102467Human1name
152131475CV1633019single nucleotide variantNM_030662.4(MAP2K2):c.529-18C>GRASopathy [RCV002136976]likely benign1941012984101298Human1name
152032962CV1643220single nucleotide variantNM_030662.4(MAP2K2):c.304-15C>GRASopathy [RCV002205080]likely benign1941106704110670Human1name
152085382CV1646778single nucleotide variantNM_030662.4(MAP2K2):c.919+11A>TRASopathy [RCV002149854]benign1940991904099190Human1name
152080559CV1663661single nucleotide variantNM_030662.4(MAP2K2):c.919+19A>CRASopathy [RCV002149254]likely benign1940991824099182Human1name
9689992CV176172single nucleotide variantNM_030662.4(MAP2K2):c.450+13G>ARASopathy [RCV002056094]|not specified [RCV000155636]benign|likely benign1941104964110496Human1name
9832797CV179831microsatelliteNM_030662.4(MAP2K2):c.-27CCG[3]RASopathy [RCV000158020]benign1941238914123893Humanname
156020653CV1903008single nucleotide variantNM_030662.4(MAP2K2):c.985-19C>TRASopathy [RCV003100178]likely benign1940954684095468Human1name
156020946CV1909523single nucleotide variantNM_030662.4(MAP2K2):c.705+18C>GRASopathy [RCV002619390]likely benign1941010014101001Human1name
156278354CV1912014single nucleotide variantNM_030662.4(MAP2K2):c.580+18C>TRASopathy [RCV002628343]likely benign1941012114101211Human1name
155941005CV1913820single nucleotide variantNM_030662.4(MAP2K2):c.706-19C>TRASopathy [RCV002615634]likely benign1940994334099433Human1name
156318302CV2025140single nucleotide variantNM_030662.4(MAP2K2):c.580+12C>TRASopathy [RCV002716930]likely benign1941012174101217Human1name
156209894CV2036805single nucleotide variantNM_030662.4(MAP2K2):c.919+16G>ARASopathy [RCV002790204]likely benign1940991854099185Human1name
156129406CV2037332single nucleotide variantNM_030662.4(MAP2K2):c.920-19C>TRASopathy [RCV002800553]likely benign1940973624097362Human1name
155958516CV2040298single nucleotide variantNM_030662.4(MAP2K2):c.920-14C>TRASopathy [RCV002776144]likely benign1940973574097357Human1name
156010859CV2042991single nucleotide variantNM_030662.4(MAP2K2):c.705+20C>GRASopathy [RCV002756677]likely benign1941009994100999Human1name
156042906CV2071719single nucleotide variantNM_030662.4(MAP2K2):c.528+12G>ARASopathy [RCV002846168]likely benign1941023644102364Human1name
156013488CV2123061single nucleotide variantNM_030662.4(MAP2K2):c.450+18A>GRASopathy [RCV002975774]likely benign1941104914110491Human1name
156159851CV2147275single nucleotide variantNM_030662.4(MAP2K2):c.451-11G>ARASopathy [RCV003023153]likely benign1941024644102464Human1name
11093343CV231024single nucleotide variantNM_030662.4(MAP2K2):c.705+11G>ARASopathy [RCV002057113]|not specified [RCV000219657]benign|likely benign1941010084101008Human1name
11544593CV257130single nucleotide variantNM_030662.4(MAP2K2):c.529-15C>TRASopathy [RCV002058363]|not specified [RCV000243998]benign|likely benign|conflicting interpretations of pathogenicity1941012954101295Human1name
11550465CV257131single nucleotide variantNM_030662.4(MAP2K2):c.528+46C>Tnot provided [RCV001689921]|not specified [RCV000251790]benign1941023304102330Humanname
401964307CV2843619single nucleotide variantNM_030662.4(MAP2K2):c.985-14G>CRASopathy [RCV003539493]|not specified [RCV003479962]likely benign1940954634095463Human1name
405158789CV2861483single nucleotide variantNM_030662.4(MAP2K2):c.705+19T>CRASopathy [RCV003539531]likely benign1941010004101000Human1name
405159728CV2874190single nucleotide variantNM_030662.4(MAP2K2):c.528+12G>TRASopathy [RCV003539619]likely benign1941023644102364Human1name
405159926CV2878425single nucleotide variantNM_030662.4(MAP2K2):c.1092+7G>ARASopathy [RCV003539634]likely benign1940944464094446Human1name
405159939CV2878426single nucleotide variantNM_030662.4(MAP2K2):c.985-16C>ARASopathy [RCV003539635]likely benign1940954654095465Human1name
405161240CV2884446single nucleotide variantNM_030662.4(MAP2K2):c.303+13G>TRASopathy [RCV003539718]likely benign1941174064117406Human1name
405162312CV2888635single nucleotide variantNM_030662.4(MAP2K2):c.706-11C>TRASopathy [RCV003540039]likely benign1940994254099425Human1name
405162654CV2907146single nucleotide variantNM_030662.4(MAP2K2):c.984+15C>ARASopathy [RCV003540226]likely benign1940972644097264Human1name
405163715CV2919244single nucleotide variantNM_030662.4(MAP2K2):c.706-15C>GRASopathy [RCV003540273]likely benign1940994294099429Human1name
405165753CV2933404single nucleotide variantNM_030662.4(MAP2K2):c.985-15T>CRASopathy [RCV003540456]likely benign1940954644095464Human1name
405050403CV3060281single nucleotide variantNM_030662.4(MAP2K2):c.919+20C>TRASopathy [RCV003654691]likely benign1940991814099181Human1name
405050790CV3068065single nucleotide variantNM_030662.4(MAP2K2):c.705+16C>GRASopathy [RCV003654720]likely benign1941010034101003Human1name
405053037CV3077703single nucleotide variantNM_030662.4(MAP2K2):c.984+12A>TRASopathy [RCV003654900]likely benign1940972674097267Human1name
405088063CV3122152single nucleotide variantNM_030662.4(MAP2K2):c.920-12C>TRASopathy [RCV003810907]likely benign1940973554097355Human1name
405164387CV3125278single nucleotide variantNM_030662.4(MAP2K2):c.920-18A>GRASopathy [RCV003818550]likely benign1940973614097361Human1name
405201216CV3128886single nucleotide variantNM_030662.4(MAP2K2):c.705+11G>TRASopathy [RCV003821929]likely benign1941010084101008Human1name
405212499CV3142619single nucleotide variantNM_030662.4(MAP2K2):c.528+15G>ARASopathy [RCV003845976]likely benign1941023614102361Human1name
405202322CV3143557single nucleotide variantNM_030662.4(MAP2K2):c.304-10C>ARASopathy [RCV003844543]likely benign1941106654110665Human1name
405187731CV3156549single nucleotide variantNM_030662.4(MAP2K2):c.304-11T>CRASopathy [RCV003859427]likely benign1941106664110666Human1name
405254349CV3175030single nucleotide variantNM_030662.4(MAP2K2):c.919+12A>CRASopathy [RCV003871482]likely benign1940991894099189Human1name
402504218CV3181377single nucleotide variantNM_030662.4(MAP2K2):c.985-18C>TRASopathy [RCV003878210]likely benign1940954674095467Human1name
596924388CV3531129deletionNM_030662.3(MAP2K2):c.93_114delnot provided [RCV004779703]uncertain significance1941176084117629Humanname
12741208CV360422single nucleotide variantNM_030662.4(MAP2K2):c.1047-3C>Tnot specified [RCV000414419]uncertain significance1940945014094501Humanname
597881987CV3744978single nucleotide variantNM_030662.4(MAP2K2):c.451-11G>CRASopathy [RCV005070003]likely benign1941024644102464Human1name
597945924CV3755464single nucleotide variantNM_030662.4(MAP2K2):c.580+10A>TRASopathy [RCV005078473]likely benign1941012194101219Human1name
597836607CV3757715single nucleotide variantNM_030662.4(MAP2K2):c.920-16C>GRASopathy [RCV005085729]likely benign1940973594097359Human1name
597833761CV3760424single nucleotide variantNM_030662.4(MAP2K2):c.528+10C>TRASopathy [RCV005085167]likely benign1941023664102366Human1name
12841795CV376555single nucleotide variantNM_030662.4(MAP2K2):c.581-20C>Tnot provided [RCV000433215]likely benign1941011634101163Humanname
12846323CV377526single nucleotide variantNM_030662.4(MAP2K2):c.919+10G>AMAP2K2-related disorder [RCV003942338]|RASopathy [RCV001478102]|not provided [RCV000441432]|not specified [RCV001175517]likely benign|uncertain significance1940991914099191Human2name , trait , alternate_id
12839211CV377528single nucleotide variantNM_030662.4(MAP2K2):c.581-19C>TRASopathy [RCV002059822]|not provided [RCV000428394]|not specified [RCV005239005]benign|likely benign1941011624101162Human1name
12841014CV377530single nucleotide variantNM_030662.4(MAP2K2):c.580+15G>ARASopathy [RCV002061589]|not provided [RCV000431819]|not specified [RCV001251291]benign|likely benign1941012144101214Human1name
12842639CV377684single nucleotide variantNM_030662.4(MAP2K2):c.920-17T>ARASopathy [RCV003539889]|not provided [RCV000434784]likely benign1940973604097360Human1name
12840038CV377688single nucleotide variantNM_030662.4(MAP2K2):c.529-14G>ARASopathy [RCV002061579]|not provided [RCV000429940]likely benign1941012944101294Human1name
12834685CV377704single nucleotide variantNM_030662.4(MAP2K2):c.528+11C>TRASopathy [RCV002061429]|not provided [RCV000420380]|not specified [RCV001778958]benign|likely benign1941023654102365Human1name
12838407CV377707single nucleotide variantNM_030662.4(MAP2K2):c.450+12C>TRASopathy [RCV002061427]|not provided [RCV000426906]likely benign1941104974110497Human1name
12839345CV379590single nucleotide variantNM_030662.4(MAP2K2):c.706-17C>TRASopathy [RCV002521780]|not provided [RCV000428646]likely benign1940994314099431Human1name
12844421CV379591single nucleotide variantNM_030662.4(MAP2K2):c.581-18G>ARASopathy [RCV002061430]|not specified [RCV000437961]benign1941011614101161Human1name
12845582CV379592single nucleotide variantNM_030662.4(MAP2K2):c.580+14C>TRASopathy [RCV002061587]|not provided [RCV000440079]likely benign1941012154101215Human1name
12843949CV379593single nucleotide variantNM_030662.4(MAP2K2):c.450+17C>TCardiofaciocutaneous syndrome 4 [RCV002502475]|RASopathy [RCV002061428]|not provided [RCV000437136]|not specified [RCV001251389]benign|likely benign1941104924110492Human2name
597971465CV3802492single nucleotide variantNM_030662.4(MAP2K2):c.580+13C>TRASopathy [RCV005142090]likely benign1941012164101216Human1name
597908480CV3806127single nucleotide variantNM_030662.4(MAP2K2):c.581-19C>ARASopathy [RCV005153885]likely benign1941011624101162Human1name
597971236CV3832771single nucleotide variantNM_030662.4(MAP2K2):c.706-20C>TRASopathy [RCV005166850]likely benign1940994344099434Human1name
597882754CV3834083single nucleotide variantNM_030662.4(MAP2K2):c.985-14G>TRASopathy [RCV005178402]likely benign1940954634095463Human1name
597902307CV3845467single nucleotide variantNM_030662.4(MAP2K2):c.705+14G>ARASopathy [RCV005181277]likely benign1941010054101005Human1name
597903308CV3845924single nucleotide variantNM_030662.4(MAP2K2):c.528+19C>GRASopathy [RCV005181546]likely benign1941023574102357Human1name
597856638CV3849748single nucleotide variantNM_030662.4(MAP2K2):c.304-18G>TRASopathy [RCV005195257]likely benign1941106734110673Human1name
597938373CV3852710single nucleotide variantNM_030662.4(MAP2K2):c.1093-8C>TRASopathy [RCV005187109]likely benign1940907164090716Human1name
12899631CV410612duplicationNM_030662.4(MAP2K2):c.1047-2dupnot provided [RCV000480641]likely benign|uncertain significance1940944994094500Humanname
12901626CV410618deletionNM_030662.4(MAP2K2):c.303+15delRASopathy [RCV002526626]|not provided [RCV000485158]benign|likely benign1941174044117404Human1name
11542368CV49259single nucleotide variantNM_030662.4(MAP2K2):c.303+18G>ACardiofaciocutaneous syndrome 4 [RCV001001924]|RASopathy [RCV002054548]|not provided [RCV001675588]|not specified [RCV000251005]benign1941174014117401Human2name
8609098CV49264single nucleotide variantNM_030662.4(MAP2K2):c.450+15G>TRASopathy [RCV002054549]|not provided [RCV001642534]|not specified [RCV000039483]benign1941104944110494Human1name
150491153CV49266single nucleotide variantNM_030662.4(MAP2K2):c.451-79C>Tnot provided [RCV001618771]benign1941025324102532Humanname
150439356CV49267single nucleotide variantNM_030662.4(MAP2K2):c.451-69G>Cnot provided [RCV001609991]benign1941025224102522Humanname
150514080CV49268single nucleotide variantNM_030662.4(MAP2K2):c.451-44G>Anot provided [RCV001598890]benign1941024974102497Humanname
150462328CV49269single nucleotide variantNM_030662.4(MAP2K2):c.451-15T>Gnot provided [RCV001710009]benign1941024684102468Humanname
11542312CV49274single nucleotide variantNM_030662.4(MAP2K2):c.528+20A>GRASopathy [RCV002054550]|not provided [RCV001711144]|not specified [RCV000246991]benign1941023564102356Human1name
150471737CV49275single nucleotide variantNM_030662.4(MAP2K2):c.529-26G>Anot provided [RCV001713247]benign1941013064101306Humanname
150472780CV49276single nucleotide variantNM_030662.4(MAP2K2):c.529-11C>Anot provided [RCV001671501]benign1941012914101291Humanname
150434387CV49279single nucleotide variantNM_030662.4(MAP2K2):c.581-29G>Anot provided [RCV001643722]benign1941011724101172Humanname
150488938CV49289single nucleotide variantNM_030662.4(MAP2K2):c.706-81G>Anot provided [RCV001674421]benign1940994954099495Humanname
150446362CV49290single nucleotide variantNM_030662.4(MAP2K2):c.706-72C>Tnot provided [RCV001667160]benign1940994864099486Humanname
150492572CV49291single nucleotide variantNM_030662.4(MAP2K2):c.706-38C>Tnot provided [RCV001619016]benign1940994524099452Humanname
150471745CV49292single nucleotide variantNM_030662.4(MAP2K2):c.706-35C>Gnot provided [RCV001713248]benign1940994494099449Humanname
8609112CV49305single nucleotide variantNM_030662.4(MAP2K2):c.919+12A>GCardiofaciocutaneous syndrome 4 [RCV000603060]|RASopathy [RCV002054551]|not provided [RCV000509309]|not specified [RCV000039497]benign|not provided1940991894099189Human2name
150445224CV49306single nucleotide variantNM_030662.4(MAP2K2):c.919+31G>Cnot provided [RCV001691088]benign1940991704099170Humanname
150510452CV49307single nucleotide variantNM_030662.4(MAP2K2):c.919+37C>Tnot provided [RCV001597588]benign1940991644099164Humanname
150471747CV49308single nucleotide variantNM_030662.4(MAP2K2):c.920-24A>Gnot provided [RCV001713249]benign1940973674097367Humanname
13536870CV497520single nucleotide variantNM_030662.4(MAP2K2):c.1046+4G>ARASopathy [RCV005091590]|not specified [RCV000609600]uncertain significance1940953844095384Human1name
13526999CV507044single nucleotide variantNM_030662.4(MAP2K2):c.450+20G>ARASopathy [RCV002065204]|not specified [RCV000604871]likely benign1941104894110489Human1name
13536656CV507386single nucleotide variantNM_030662.4(MAP2K2):c.581-11G>Anot specified [RCV000609314]likely benign1941011544101154Humanname
13533643CV507388single nucleotide variantNM_030662.4(MAP2K2):c.529-10T>Cnot specified [RCV000607156]likely benign|conflicting interpretations of pathogenicity1941012904101290Humanname
13796612CV553041single nucleotide variantNM_030662.4(MAP2K2):c.450+99A>Gnot provided [RCV000680664]benign1941104104110410Humanname
13797606CV553044single nucleotide variantNM_030662.4(MAP2K2):c.92+266G>Anot provided [RCV000681336]likely benign1941235184123518Humanname
8609083CV55390microsatelliteNM_030662.4(MAP2K2):c.-27CCG[6]not specified [RCV000039468]benign|likely benign|conflicting interpretations of pathogenicity1941238904123891Humanname
8609086CV55393single nucleotide variantNM_030662.4(MAP2K2):c.1093-6T>CCardiofaciocutaneous syndrome 4 [RCV003741149]|RASopathy [RCV000463260]|not provided [RCV000590120]|not specified [RCV000039471]benign|likely benign1940907144090714Human2name
8609093CV55398single nucleotide variantNM_030662.4(MAP2K2):c.303+12G>ARASopathy [RCV002054765]|not specified [RCV000039478]benign|likely benign|conflicting interpretations of pathogenicity1941174074117407Human1name
8609097CV55401single nucleotide variantNM_030662.4(MAP2K2):c.450+14G>ARASopathy [RCV002054766]|not specified [RCV000039482]likely benign|conflicting interpretations of pathogenicity1941104954110495Human1name
8609107CV55406single nucleotide variantNM_030662.4(MAP2K2):c.705+10C>TRASopathy [RCV002054767]|not provided [RCV000680363]|not specified [RCV000039492]likely benign1941010094101009Human1name
15131693CV685459single nucleotide variantNM_030662.4(MAP2K2):c.581-10C>TRASopathy [RCV001421050]likely benign1941011534101153Human1name
38598306CV963305single nucleotide variantNM_030662.4(MAP2K2):c.705+15G>Anot specified [RCV001251319]uncertain significance1941010044101004Humanname
40903243CV975839single nucleotide variantNM_030662.4(MAP2K2):c.1047-6C>Anot specified [RCV001269160]uncertain significance1940945044094504Humanname
150421397CV1199129single nucleotide variantNM_030662.4(MAP2K2):c.1047-31G>Anot provided [RCV001578020]likely benign1940945294094529Humanname
150506500CV1212222single nucleotide variantNM_030662.4(MAP2K2):c.304-127G>Anot provided [RCV001596053]likely benign1941107824110782Humanname
150462943CV1214716single nucleotide variantNM_030662.4(MAP2K2):c.528+118A>Gnot provided [RCV001613709]benign1941022584102258Humanname
150472659CV1235095deletionNM_030662.4(MAP2K2):c.984+251delnot provided [RCV001651464]benign1940970284097028Humanname
150473094CV1235169single nucleotide variantNM_030662.4(MAP2K2):c.451-172A>Gnot provided [RCV001651538]benign1941026254102625Humanname
150464542CV1241316single nucleotide variantNM_030662.4(MAP2K2):c.450+189C>Gnot provided [RCV001649827]benign1941103204110320Humanname
150468576CV1259517single nucleotide variantNM_030662.4(MAP2K2):c.303+118C>Gnot provided [RCV001683817]benign1941173014117301Humanname
150451404CV1260254duplicationNM_030662.4(MAP2K2):c.984+235dupnot provided [RCV001680744]benign1940970274097028Humanname
150440907CV1265476single nucleotide variantNM_030662.4(MAP2K2):c.984+307C>Tnot provided [RCV001679179]benign1940969724096972Humanname
151750940CV1415847single nucleotide variantNM_030662.4(MAP2K2):c.1092+15C>TRASopathy [RCV001927513]likely benign|uncertain significance1940944384094438Human1name
8691899CV141866single nucleotide variantNM_030662.4(MAP2K2):c.1046+13G>ARASopathy [RCV002055667]|not specified [RCV000126680]benign|likely benign1940953754095375Human1name
151844611CV1457861single nucleotide variantNM_030662.4(MAP2K2):c.1093-19G>ARASopathy [RCV001936537]likely benign|uncertain significance1940907274090727Human1name
152107862CV1579626single nucleotide variantNM_030662.4(MAP2K2):c.1092+16G>ARASopathy [RCV002173954]likely benign1940944374094437Human1name
152034629CV1634967single nucleotide variantNM_030662.4(MAP2K2):c.1093-19G>TRASopathy [RCV002087003]likely benign1940907274090727Human1name
152129662CV1650621single nucleotide variantNM_030662.4(MAP2K2):c.1092+14G>TRASopathy [RCV002118912]likely benign1940944394094439Human1name
155954370CV1936251single nucleotide variantNM_030662.4(MAP2K2):c.706-350C>Tnot provided [RCV002511912]benign|likely benign1940997644099764Humanname
156115617CV2084919single nucleotide variantNM_030662.4(MAP2K2):c.1093-16T>CRASopathy [RCV002889358]likely benign1940907244090724Human1name
405050243CV3053939single nucleotide variantNM_030662.4(MAP2K2):c.1046+12C>TRASopathy [RCV003654598]likely benign1940953764095376Human1name
405249633CV3170037single nucleotide variantNM_030662.4(MAP2K2):c.1047-20C>TRASopathy [RCV003869666]likely benign1940945184094518Human1name
597913301CV3806660single nucleotide variantNM_030662.4(MAP2K2):c.1046+14G>CRASopathy [RCV005154227]likely benign1940953744095374Human1name
597915380CV3833813single nucleotide variantNM_030662.4(MAP2K2):c.1093-13C>TRASopathy [RCV005183172]likely benign1940907214090721Human1name
597929870CV3837466single nucleotide variantNM_030662.4(MAP2K2):c.1046+10G>ARASopathy [RCV005185624]likely benign1940953784095378Human1name
597905651CV3846581single nucleotide variantNM_030662.4(MAP2K2):c.1093-20C>TRASopathy [RCV005182008]likely benign1940907284090728Human1name
150438719CV49265single nucleotide variantNM_030662.4(MAP2K2):c.451-135C>Tnot provided [RCV001665984]benign1941025884102588Humanname
13525012CV507825single nucleotide variantNM_030662.4(MAP2K2):c.1046+16C>ARASopathy [RCV002062865]|not specified [RCV000602572]likely benign1940953724095372Human1name
13796773CV553032single nucleotide variantNM_030662.4(MAP2K2):c.985-150C>Gnot provided [RCV000680746]benign1940955994095599Humanname
13797475CV553033single nucleotide variantNM_030662.4(MAP2K2):c.919+252C>Tnot provided [RCV000681247]benign1940989494098949Humanname
13796748CV553034single nucleotide variantNM_030662.4(MAP2K2):c.705+179T>Cnot provided [RCV000680733]benign1941008404100840Humanname
13796642CV553035single nucleotide variantNM_030662.4(MAP2K2):c.705+128C>Tnot provided [RCV000680679]likely benign1941008914100891Humanname
13796745CV553037single nucleotide variantNM_030662.4(MAP2K2):c.529-138G>Anot provided [RCV000680731]benign1941014184101418Humanname
13796889CV553038single nucleotide variantNM_030662.4(MAP2K2):c.528+242T>Gnot provided [RCV000680864]benign1941021344102134Humanname
13797094CV553039single nucleotide variantNM_030662.4(MAP2K2):c.528+237T>Cnot provided [RCV000680960]benign1941021394102139Humanname
13797599CV553040single nucleotide variantNM_030662.4(MAP2K2):c.450+307C>Anot provided [RCV000681334]likely benign1941102024110202Humanname
13796567CV553042single nucleotide variantNM_030662.4(MAP2K2):c.303+127A>Gnot provided [RCV000680656]benign1941172924117292Humanname
150425174CV1185486single nucleotide variantNM_030662.4(MAP2K2):c.1093-128G>Anot provided [RCV001557658]likely benign1940908364090836Humanname
150426303CV1188777single nucleotide variantNM_030662.4(MAP2K2):c.1092+127G>Anot provided [RCV001559399]likely benign1940943264094326Humanname
152107365CV1605264single nucleotide variantNM_030662.4(MAP2K2):c.1092+341C>ARASopathy [RCV002196328]benign1940941124094112Human1name
155641627CV1709875single nucleotide variantNM_030662.4(MAP2K2):c.1047-391C>Tnot provided [RCV002292975]benign|likely benign1940948894094889Humanname
401908241CV2815194single nucleotide variantNM_030662.4(MAP2K2):c.1047-366G>Tnot provided [RCV003423208]benign1940948644094864Humanname
405161018CV2883322microsatelliteNM_030662.4(MAP2K2):c.920-17TC[3]RASopathy [RCV003540115]likely benign1940973534097354Humanname
13797747CV553025single nucleotide variantNM_030662.4(MAP2K2):c.1093-273C>Tnot provided [RCV000681401]likely benign1940909814090981Humanname
13796767CV553027single nucleotide variantNM_030662.4(MAP2K2):c.1047-212G>Anot provided [RCV000680742]likely benign1940947104094710Humanname
13797477CV553028single nucleotide variantNM_030662.4(MAP2K2):c.1047-279C>Tnot provided [RCV000681248]benign1940947774094777Humanname
13797697CV553029deletionNM_030662.4(MAP2K2):c.1046+303delnot provided [RCV000681375]likely benign1940950854095085Humanname
13796785CV553030single nucleotide variantNM_030662.4(MAP2K2):c.1046+200C>Tnot provided [RCV000680753]likely benign1940951884095188Humanname
156108925CV2108145deletionNM_030662.4(MAP2K2):c.578_580+9delRASopathy [RCV002927340]uncertain significance1941012204101231Human1name
156371758CV1993532single nucleotide variantNM_030662.4(MAP2K2):c.4C>T (p.Leu2=)RASopathy [RCV002652956]likely benign1941238724123872Human1name
15122316CV695823microsatelliteNM_030662.4(MAP2K2):c.985-7_985-5delRASopathy [RCV000874392]|not specified [RCV001824901]likely benign|uncertain significance1940954544095456Humanname
405164002CV2921008single nucleotide variantNM_030662.4(MAP2K2):c.21G>A (p.Pro7=)RASopathy [RCV003540333]likely benign1941238554123855Human1name
597905913CV3846631single nucleotide variantNM_030662.4(MAP2K2):c.12G>A (p.Arg4=)RASopathy [RCV005182058]likely benign1941238644123864Human1name
150516623CV1227155deletionNM_030662.4(MAP2K2):c.92+152_92+178delnot provided [RCV001639253]benign1941236064123632Humanname
152157709CV1541836deletionNM_030662.4(MAP2K2):c.706-15_706-14delRASopathy [RCV002103194]likely benign1940994284099429Human1name
152111408CV1552419single nucleotide variantNM_030662.4(MAP2K2):c.66A>G (p.Pro22=)Cardiovascular phenotype [RCV004990710]|RASopathy [RCV002134532]likely benign1941238104123810Human1name
152155962CV1561066single nucleotide variantNM_030662.4(MAP2K2):c.30G>A (p.Pro10=)RASopathy [RCV002102943]likely benign1941238464123846Human1name
155727004CV1822376single nucleotide variantNM_030662.4(MAP2K2):c.69C>T (p.Ser23=)Cardiovascular phenotype [RCV002364745]likely benign1941238074123807Humanname
405162034CV2906387inversionNM_030662.4(MAP2K2):c.528+19_528+20invRASopathy [RCV003540198]uncertain significance1941023564102357Humanname
405060882CV3007988single nucleotide variantNM_030662.4(MAP2K2):c.30G>C (p.Pro10=)RASopathy [RCV003655930]likely benign1941238464123846Human1name
405084771CV3167278microsatelliteNM_030662.4(MAP2K2):c.451-20_451-17delRASopathy [RCV003851859]likely benign1941024704102473Humanname
405683301CV3387825single nucleotide variantNM_030662.4(MAP2K2):c.54C>T (p.Ile18=)Cardiovascular phenotype [RCV004517800]likely benign1941238224123822Humanname
596945295CV3547809single nucleotide variantNM_030662.4(MAP2K2):c.84C>A (p.Gly28=)not provided [RCV004809140]likely benign1941237924123792Humanname
597729924CV3699989single nucleotide variantNM_030662.4(MAP2K2):c.48T>C (p.Pro16=)Cardiovascular phenotype [RCV004995638]likely benign1941238284123828Humanname
12840828CV377537single nucleotide variantNM_030662.4(MAP2K2):c.42C>T (p.Ile14=)not provided [RCV000431447]|not specified [RCV001193492]likely benign1941238344123834Humanname
12888926CV403730single nucleotide variantNM_030662.4(MAP2K2):c.39C>T (p.Thr13=)Cardiovascular phenotype [RCV003168916]|RASopathy [RCV000471846]|not provided [RCV002225631]|not specified [RCV000586167]likely benign|uncertain significance1941238374123837Human1name
13477613CV442542single nucleotide variantNM_030662.4(MAP2K2):c.45C>T (p.Asn15=)RASopathy [RCV000520444]likely benign1941238314123831Human1name
8691900CV49233single nucleotide variantNM_030662.3(MAP2K2):c.8C>T (p.Ala3Val)not provided [RCV000126681]benign1941238684123868Humanname
9832814CV49234deletionNM_030662.4(MAP2K2):c.22del (p.Val8fs)RASopathy [RCV000158044]uncertain significance1941238544123854Human1name
13626547CV533121single nucleotide variantNM_030662.4(MAP2K2):c.96A>G (p.Ala32=)RASopathy [RCV000654994]likely benign1941176264117626Human1name
13796794CV553045microsatelliteNM_030662.4(MAP2K2):c.92+212_92+237delnot provided [RCV000680758]benign1941235474123572Humanname
14699183CV624658single nucleotide variantNM_030662.4(MAP2K2):c.7G>T (p.Ala3Ser)Cardiofaciocutaneous syndrome 4 [RCV005029451]|not provided [RCV000788439]uncertain significance1941238694123869Human1name
8611990CV65596single nucleotide variantNM_030662.4(MAP2K2):c.33G>A (p.Ala11=)Cardiovascular phenotype [RCV002453344]|RASopathy [RCV000655007]|not specified [RCV000043640]benign|likely benign|conflicting interpretations of pathogenicity1941238434123843Human1name
127235102CV1084747single nucleotide variantNM_030662.4(MAP2K2):c.282G>A (p.Ser94=)Cardiovascular phenotype [RCV002438963]|RASopathy [RCV001414356]likely benign1941174404117440Human1name
127235819CV1106530single nucleotide variantNM_030662.4(MAP2K2):c.186C>T (p.Ala62=)RASopathy [RCV001433194]likely benign1941175364117536Human1name
150453093CV1205606deletionNM_030662.4(MAP2K2):c.303+92_303+128delnot provided [RCV001585507]likely benign1941172914117327Humanname
151352164CV1325121single nucleotide variantNM_030662.4(MAP2K2):c.237C>T (p.Gly79=)Cardiovascular phenotype [RCV002458621]|Noonan syndrome and Noonan-related syndrome [RCV001813677]|RASopathy [RCV002542453]|not provided [RCV005428429]likely benign|uncertain significance1941174854117485Human1name
151352165CV1325122single nucleotide variantNM_030662.4(MAP2K2):c.102G>C (p.Leu34=)Noonan syndrome and Noonan-related syndrome [RCV001813678]|RASopathy [RCV005095228]likely benign|uncertain significance1941176204117620Human1name
152106521CV1577629single nucleotide variantNM_030662.4(MAP2K2):c.160C>T (p.Leu54=)RASopathy [RCV002096243]likely benign1941175624117562Human1name
152135736CV1624583single nucleotide variantNM_030662.4(MAP2K2):c.291C>T (p.Ile97=)RASopathy [RCV002177393]likely benign1941174314117431Human1name
152047885CV1627457single nucleotide variantNM_030662.4(MAP2K2):c.216C>T (p.Phe72=)Cardiovascular phenotype [RCV005375053]|RASopathy [RCV002108564]likely benign1941175064117506Human1name
9832820CV179829deletionNM_030662.4(MAP2K2):c.71del (p.Pro24fs)RASopathy [RCV000158050]uncertain significance1941238054123805Human1name
9832819CV179830single nucleotide variantNM_030662.4(MAP2K2):c.10C>T (p.Arg4Trp)not provided [RCV000158049]uncertain significance1941238664123866Humanname
155722314CV1831323single nucleotide variantNM_030662.4(MAP2K2):c.171T>C (p.Phe57=)Cardiovascular phenotype [RCV002399052]likely benign1941175514117551Humanname
156156603CV1931577single nucleotide variantNM_030662.4(MAP2K2):c.279C>G (p.Pro93=)RASopathy [RCV002664087]likely benign1941174434117443Human1name
156437000CV1936824single nucleotide variantNM_030662.4(MAP2K2):c.168C>G (p.Ala56=)RASopathy [RCV003106527]likely benign1941175544117554Human1name
156162543CV2070619single nucleotide variantNM_030662.4(MAP2K2):c.17A>G (p.Lys6Arg)RASopathy [RCV002851265]uncertain significance1941238594123859Human1name
156027011CV2108839single nucleotide variantNM_030662.4(MAP2K2):c.150G>A (p.Gln50=)RASopathy [RCV002909888]likely benign1941175724117572Human1name
11092388CV231027single nucleotide variantNM_030662.4(MAP2K2):c.174C>T (p.Leu58=)RASopathy [RCV002517479]|not specified [RCV000218473]likely benign1941175484117548Human1name
401766350CV2732259single nucleotide variantNM_030662.4(MAP2K2):c.232C>T (p.Leu78=)Cardiovascular phenotype [RCV003301797]likely benign1941174904117490Humanname
405057280CV2964084single nucleotide variantNM_030662.4(MAP2K2):c.255G>A (p.Val85=)RASopathy [RCV003655643]likely benign1941174674117467Human1name
405060643CV2993673single nucleotide variantNM_030662.4(MAP2K2):c.234G>A (p.Leu78=)RASopathy [RCV003655911]likely benign1941174884117488Human1name
405062410CV3025207single nucleotide variantNM_030662.4(MAP2K2):c.162G>A (p.Leu54=)RASopathy [RCV003656052]likely benign1941175604117560Human1name
405050232CV3046382single nucleotide variantNM_030662.4(MAP2K2):c.165A>G (p.Glu55=)RASopathy [RCV003654578]likely benign1941175574117557Human1name
402511766CV3178302single nucleotide variantNM_030662.4(MAP2K2):c.183A>G (p.Lys61=)RASopathy [RCV003878919]likely benign1941175394117539Human1name
405268460CV3187046single nucleotide variantNM_030662.4(MAP2K2):c.288C>T (p.Leu96=)not provided [RCV003887129]likely benign1941174344117434Humanname
12845697CV377711single nucleotide variantNM_030662.4(MAP2K2):c.240G>A (p.Ala80=)Cardiovascular phenotype [RCV002446659]|MAP2K2-related disorder [RCV003922721]|RASopathy [RCV000523706]|not provided [RCV000590354]benign|likely benign1941174824117482Human2name , trait , alternate_id
597889340CV3804820single nucleotide variantNM_030662.4(MAP2K2):c.237C>G (p.Gly79=)RASopathy [RCV005151082]likely benign1941174854117485Human1name
12887979CV403261single nucleotide variantNM_030662.4(MAP2K2):c.279C>T (p.Pro93=)RASopathy [RCV001426020]likely benign1941174434117443Human1name
13504511CV442540single nucleotide variantNM_030662.4(MAP2K2):c.225C>T (p.Ile75=)Cardiovascular phenotype [RCV002448566]|MAP2K2-related disorder [RCV003960232]|RASopathy [RCV000520281]|not provided [RCV004584737]|not specified [RCV003387865]benign|likely benign1941174974117497Human2name , trait , alternate_id
13489457CV442541single nucleotide variantNM_030662.4(MAP2K2):c.141C>T (p.Asp47=)Cardiovascular phenotype [RCV002395242]|Noonan syndrome and Noonan-related syndrome [RCV001813495]|RASopathy [RCV000523895]|not provided [RCV001637063]benign|likely benign1941175814117581Human1name
13481140CV442543single nucleotide variantNM_030662.3(MAP2K2):c.14G>A (p.Arg5Lys)Rasopathy [RCV000521428]benign1941238624123862Humanname
13466686CV468821single nucleotide variantNM_030662.4(MAP2K2):c.207C>T (p.Asp69=)Cardiovascular phenotype [RCV002420542]|RASopathy [RCV000552205]|not provided [RCV001556214]|not specified [RCV000588692]likely benign|uncertain significance1941175154117515Human1name
13813739CV49235single nucleotide variantNM_030662.4(MAP2K2):c.26T>C (p.Leu9Pro)Cardiovascular phenotype [RCV002426539]|Noonan syndrome [RCV000824941]|RASopathy [RCV000704590]|not specified [RCV001251263]uncertain significance1941238504123850Human2name
8609088CV49240single nucleotide variantNM_030662.4(MAP2K2):c.192C>T (p.Val64=)Cardiofaciocutaneous syndrome 4 [RCV000999991]|Cardiovascular phenotype [RCV002408500]|RASopathy [RCV000473659]|not provided [RCV004716914]|not specified [RCV000039473]benign1941175304117530Human2name
13482806CV49257single nucleotide variantNM_030662.4(MAP2K2):c.291C>A (p.Ile97=)Cardiovascular phenotype [RCV002433490]|Noonan syndrome and Noonan-related syndrome [RCV001813311]|RASopathy [RCV000521884]|not provided [RCV001668150]benign|likely benign1941174314117431Human1name
13529425CV506834single nucleotide variantNM_030662.4(MAP2K2):c.168C>T (p.Ala56=)RASopathy [RCV002528536]|not specified [RCV000600305]likely benign1941175544117554Human1name
13525249CV507401single nucleotide variantNM_030662.4(MAP2K2):c.258C>T (p.Val86=)RASopathy [RCV005091663]|not specified [RCV000602906]likely benign1941174644117464Human1name
8609089CV55394single nucleotide variantNM_030662.4(MAP2K2):c.246C>T (p.Asn82=)Cardiovascular phenotype [RCV002453321]|RASopathy [RCV002054764]|not specified [RCV000039474]benign|likely benign|conflicting interpretations of pathogenicity1941174764117476Human1name
8609090CV55395single nucleotide variantNM_030662.4(MAP2K2):c.258C>A (p.Val86=)Cardiofaciocutaneous syndrome 4 [RCV003741150]|Cardiovascular phenotype [RCV002453322]|RASopathy [RCV001078949]|not provided [RCV000680292]|not specified [RCV000039475]pathogenic|likely pathogenic|benign|likely benign1941174644117464Human2name
14732452CV648138single nucleotide variantNM_030662.4(MAP2K2):c.195C>T (p.Gly65=)RASopathy [RCV000801847]likely benign|uncertain significance1941175274117527Human1name
14703083CV653050indelNM_030662.4(MAP2K2):c.706-1_706delinsTTCardiofaciocutaneous syndrome 4 [RCV005021230]|RASopathy [RCV000811084]|not provided [RCV004777887]|not specified [RCV000825042]uncertain significance1940994144099415Humanname
15149361CV757039single nucleotide variantNM_030662.4(MAP2K2):c.228A>C (p.Ser76=)not provided [RCV000923272]likely benign1941174944117494Humanname
38496846CV958644single nucleotide variantNM_030662.4(MAP2K2):c.249C>T (p.Gly83=)RASopathy [RCV001242818]likely benign|uncertain significance1941174734117473Human1name
126913064CV1038721single nucleotide variantNM_030662.4(MAP2K2):c.52A>T (p.Ile18Phe)not provided [RCV001357033]uncertain significance1941238244123824Humanname
126919746CV1051330single nucleotide variantNM_030662.4(MAP2K2):c.351C>T (p.Arg117=)RASopathy [RCV001373409]likely benign|uncertain significance1941106084110608Human1name
127236605CV1084741single nucleotide variantNM_030662.4(MAP2K2):c.912C>A (p.Pro304=)RASopathy [RCV001396927]likely benign1940992084099208Human1name
127279930CV1084743single nucleotide variantNM_030662.4(MAP2K2):c.786C>T (p.Val262=)Cardiovascular phenotype [RCV002413971]|RASopathy [RCV001409415]likely benign1940993344099334Human1name
127247665CV1084744single nucleotide variantNM_030662.4(MAP2K2):c.570C>T (p.Ile190=)RASopathy [RCV001394299]likely benign1941012394101239Human1name
127249602CV1084745single nucleotide variantNM_030662.4(MAP2K2):c.546G>C (p.Ala182=)Cardiovascular phenotype [RCV002350760]|RASopathy [RCV001399633]likely benign1941012634101263Human1name
127248037CV1084746single nucleotide variantNM_030662.4(MAP2K2):c.447C>T (p.His149=)RASopathy [RCV001394365]likely benign1941105124110512Human1name
127277540CV1106527single nucleotide variantNM_030662.4(MAP2K2):c.696C>T (p.Ser232=)RASopathy [RCV001444476]|not provided [RCV003426101]likely benign1941010284101028Human1name
127278194CV1106529single nucleotide variantNM_030662.4(MAP2K2):c.423G>A (p.Gly141=)Cardiovascular phenotype [RCV002329503]|RASopathy [RCV001444887]likely benign1941105364110536Human1name
127290049CV1148866single nucleotide variantNM_030662.4(MAP2K2):c.903C>G (p.Pro301=)RASopathy [RCV001495863]likely benign1940992174099217Human1name
127312045CV1148867single nucleotide variantNM_030662.4(MAP2K2):c.885G>A (p.Ser295=)Cardiovascular phenotype [RCV003284356]|RASopathy [RCV001501794]likely benign1940992354099235Human1name
127318210CV1148868single nucleotide variantNM_030662.4(MAP2K2):c.744G>A (p.Ser248=)RASopathy [RCV001503600]likely benign1940993764099376Human1name
127329011CV1148869single nucleotide variantNM_030662.4(MAP2K2):c.510G>A (p.Leu170=)Cardiovascular phenotype [RCV002342100]|RASopathy [RCV001487152]likely benign1941023944102394Human1name
127337581CV1148870single nucleotide variantNM_030662.4(MAP2K2):c.339C>T (p.Asn113=)Cardiovascular phenotype [RCV002456880]|RASopathy [RCV001492927]likely benign1941106204110620Human1name
150332204CV1163747single nucleotide variantNM_030662.4(MAP2K2):c.528G>A (p.Ala176=)Cardiofaciocutaneous syndrome 4 [RCV001528135]|RASopathy [RCV001873729]likely pathogenic|uncertain significance1941023764102376Human2name
150331925CV1169831single nucleotide variantNM_030662.4(MAP2K2):c.810C>T (p.Pro270=)Cardiovascular phenotype [RCV002421181]|RASopathy [RCV002071927]|not provided [RCV001536683]likely benign1940993104099310Human1name
150428969CV1188778single nucleotide variantNM_030662.4(MAP2K2):c.924C>T (p.His308=)RASopathy [RCV003771721]|not provided [RCV001562972]likely benign1940973394097339Human1name
150516915CV1227354deletionNM_030662.4(MAP2K2):c.984+250_984+251delnot provided [RCV001639455]benign1940970284097029Humanname
150531317CV1299382single nucleotide variantNM_030662.4(MAP2K2):c.74C>A (p.Thr25Asn)not provided [RCV001757075]uncertain significance1941238024123802Humanname
150553571CV1303580deletionNM_030662.4(MAP2K2):c.206del (p.Asp69fs)not provided [RCV001769270]uncertain significance1941175164117516Humanname
151234554CV1320322single nucleotide variantNM_030662.4(MAP2K2):c.912C>T (p.Pro304=)Cardiovascular phenotype [RCV002370325]|RASopathy [RCV002074146]|not provided [RCV001799946]|not specified [RCV003994330]likely benign1940992084099208Human1name
151352158CV1325117single nucleotide variantNM_030662.4(MAP2K2):c.951C>T (p.Ala317=)Cardiovascular phenotype [RCV004996019]|Noonan syndrome and Noonan-related syndrome [RCV001813673]|RASopathy [RCV002074234]likely benign|uncertain significance1940973124097312Human1name
151352161CV1325119single nucleotide variantNM_030662.4(MAP2K2):c.627G>A (p.Lys209=)Noonan syndrome and Noonan-related syndrome [RCV001813675]uncertain significance1941010974101097Humanname
151352167CV1325123single nucleotide variantNM_030662.4(MAP2K2):c.85G>T (p.Ala29Ser)Noonan syndrome and Noonan-related syndrome [RCV001813679]|RASopathy [RCV005095229]uncertain significance1941237914123791Human1name
151354565CV1329698single nucleotide variantNM_030662.4(MAP2K2):c.895A>C (p.Arg299=)Cardiovascular phenotype [RCV002370343]|not specified [RCV001818063]likely benign1940992254099225Humanname
8691894CV141861single nucleotide variantNM_030662.4(MAP2K2):c.546G>A (p.Ala182=)Cardiovascular phenotype [RCV002345435]|RASopathy [RCV000226018]|not specified [RCV000126673]benign|likely benign|conflicting interpretations of pathogenicity1941012634101263Human1name
8691895CV141862single nucleotide variantNM_030662.4(MAP2K2):c.690G>A (p.Thr230=)Cardiofaciocutaneous syndrome 4 [RCV003114276]|Cardiovascular phenotype [RCV002362765]|MAP2K2-related disorder [RCV003975121]|Noonan syndrome and Noonan-related syndrome [RCV001813386]|RASopathy [RCV000232567]|not provided [RCV000589657]|not specified [RCV000126benign|likely benign1941010344101034Human2name , trait , alternate_id
8691897CV141864single nucleotide variantNM_030662.4(MAP2K2):c.825G>A (p.Leu275=)Cardiovascular phenotype [RCV002426686]|MAP2K2-related disorder [RCV003965051]|RASopathy [RCV000524027]|not provided [RCV000589791]|not specified [RCV000126677]benign|likely benign1940992954099295Human2name , trait , alternate_id
152120769CV1521339single nucleotide variantNM_030662.4(MAP2K2):c.768C>G (p.Ser256=)RASopathy [RCV002135679]|not provided [RCV004809790]likely benign1940993524099352Human1name
152078343CV1564839single nucleotide variantNM_030662.4(MAP2K2):c.381G>A (p.Ser127=)RASopathy [RCV002192714]likely benign1941105784110578Human1name
152103865CV1569884single nucleotide variantNM_030662.4(MAP2K2):c.852C>G (p.Val284=)RASopathy [RCV002195888]likely benign1940992684099268Human1name
152054059CV1574199single nucleotide variantNM_030662.4(MAP2K2):c.876C>T (p.His292=)RASopathy [RCV002189747]likely benign1940992444099244Human1name
152128961CV1599857single nucleotide variantNM_030662.4(MAP2K2):c.642G>A (p.Gly214=)RASopathy [RCV002136684]likely benign1941010824101082Human1name
152160719CV1601745single nucleotide variantNM_030662.4(MAP2K2):c.735G>A (p.Ser245=)Cardiovascular phenotype [RCV002382384]|RASopathy [RCV002180884]likely benign1940993854099385Human1name
152132909CV1621512single nucleotide variantNM_030662.4(MAP2K2):c.597C>T (p.Asn199=)RASopathy [RCV002218318]likely benign1941011274101127Human1name
152095475CV1653091single nucleotide variantNM_030662.4(MAP2K2):c.807G>T (p.Pro269=)Cardiovascular phenotype [RCV002409484]|RASopathy [RCV002094778]likely benign1940993134099313Human1name
152060744CV1659734single nucleotide variantNM_030662.4(MAP2K2):c.459C>A (p.Gly153=)Cardiovascular phenotype [RCV002337247]|RASopathy [RCV002073645]likely benign1941024454102445Human1name
9690476CV176029single nucleotide variantNM_030662.4(MAP2K2):c.639C>T (p.Phe213=)Cardiovascular phenotype [RCV004992030]|RASopathy [RCV003114306]|not provided [RCV000680624]|not specified [RCV000156156]likely benign1941010854101085Human1name
9691800CV176030single nucleotide variantNM_030662.4(MAP2K2):c.564C>T (p.His188=)Cardiovascular phenotype [RCV004019813]|not specified [RCV000151008]likely benign1941012454101245Humanname
9691801CV176173single nucleotide variantNM_030662.4(MAP2K2):c.384G>A (p.Pro128=)Cardiovascular phenotype [RCV004992021]|MAP2K2-related disorder [RCV004745217]|RASopathy [RCV001476321]|not specified [RCV000151010]likely benign1941105754110575Human2name , trait , alternate_id
155664178CV1789786single nucleotide variantNM_030662.4(MAP2K2):c.369C>T (p.His123=)Cardiovascular phenotype [RCV002348877]|RASopathy [RCV005096354]|not specified [RCV004782923]likely benign1941105904110590Human1name
155666374CV1793105single nucleotide variantNM_030662.4(MAP2K2):c.363C>T (p.Val121=)Cardiovascular phenotype [RCV002452415]likely benign1941105964110596Humanname
155669182CV1800031single nucleotide variantNM_030662.4(MAP2K2):c.546G>T (p.Ala182=)Cardiovascular phenotype [RCV002349785]likely benign1941012634101263Humanname
155666907CV1803108single nucleotide variantNM_030662.4(MAP2K2):c.540C>T (p.Gly180=)Cardiovascular phenotype [RCV002349409]likely benign1941012694101269Humanname
155728056CV1812871single nucleotide variantNM_030662.4(MAP2K2):c.726A>G (p.Thr242=)Cardiovascular phenotype [RCV002382565]likely benign1940993944099394Humanname
155714395CV1815280single nucleotide variantNM_030662.4(MAP2K2):c.684G>A (p.Val228=)Cardiovascular phenotype [RCV002362109]likely benign1941010404101040Humanname
155666566CV1819546single nucleotide variantNM_030662.4(MAP2K2):c.741G>A (p.Gln247=)Cardiovascular phenotype [RCV002384976]|MAP2K2-related disorder [RCV003903684]likely benign1940993794099379Human1name , trait , alternate_id
155705279CV1824118single nucleotide variantNM_030662.4(MAP2K2):c.843G>A (p.Arg281=)Cardiovascular phenotype [RCV002445940]likely benign1940992774099277Humanname
155698927CV1824494single nucleotide variantNM_030662.4(MAP2K2):c.888T>G (p.Pro296=)Cardiovascular phenotype [RCV002376009]likely benign1940992324099232Humanname
155684693CV1824975single nucleotide variantNM_030662.4(MAP2K2):c.937C>A (p.Arg313=)Cardiovascular phenotype [RCV002371744]likely benign1940973264097326Humanname
156362519CV1881371single nucleotide variantNM_030662.4(MAP2K2):c.570C>A (p.Ile190=)RASopathy [RCV003065719]likely benign1941012394101239Human1name
156408720CV1911739single nucleotide variantNM_030662.4(MAP2K2):c.879C>T (p.Ser293=)RASopathy [RCV002607325]likely benign1940992414099241Human1name
156296760CV1924160single nucleotide variantNM_030662.4(MAP2K2):c.889C>A (p.Arg297=)RASopathy [RCV002629050]likely benign1940992314099231Human1name
156122594CV1952802single nucleotide variantNM_030662.4(MAP2K2):c.73A>G (p.Thr25Ala)RASopathy [RCV002571923]uncertain significance1941238034123803Human1name
10052855CV195430single nucleotide variantNM_030662.4(MAP2K2):c.648C>T (p.Ser216=)RASopathy [RCV002054134]|not provided [RCV000179542]|not specified [RCV001844072]likely benign|uncertain significance1941010764101076Human1name
10053081CV195756single nucleotide variantNM_030662.4(MAP2K2):c.763C>T (p.Leu255=)not provided [RCV000179979]uncertain significance1940993574099357Humanname
156200941CV2024541single nucleotide variantNM_030662.4(MAP2K2):c.83G>A (p.Gly28Asp)RASopathy [RCV002711397]uncertain significance1941237934123793Human1name
156131376CV2084918deletionNM_030662.4(MAP2K2):c.1093-14_1093-11delRASopathy [RCV002871646]likely benign1940907194090722Human1name
156101824CV2088040single nucleotide variantNM_030662.4(MAP2K2):c.508C>T (p.Leu170=)RASopathy [RCV002848113]likely benign1941023964102396Human1name
156152879CV2098548single nucleotide variantNM_030662.4(MAP2K2):c.463C>T (p.Leu155=)RASopathy [RCV002890713]likely benign1941024414102441Human1name
156153947CV2098613single nucleotide variantNM_030662.4(MAP2K2):c.807G>A (p.Pro269=)RASopathy [RCV002890749]likely benign1940993134099313Human1name
156056331CV2102044single nucleotide variantNM_030662.4(MAP2K2):c.963C>A (p.Leu321=)RASopathy [RCV002886340]likely benign1940973004097300Human1name
155947735CV2108193single nucleotide variantNM_030662.4(MAP2K2):c.79G>A (p.Glu27Lys)RASopathy [RCV002904875]uncertain significance1941237974123797Human1name
156237037CV2118470single nucleotide variantNM_030662.4(MAP2K2):c.715T>C (p.Leu239=)RASopathy [RCV002958731]likely benign1940994054099405Human1name
156030400CV2141978single nucleotide variantNM_030662.4(MAP2K2):c.999G>A (p.Leu333=)RASopathy [RCV002976579]likely benign1940954354095435Human1name
156270202CV2178946single nucleotide variantNM_030662.4(MAP2K2):c.792G>A (p.Arg264=)RASopathy [RCV003044426]likely benign1940993284099328Human1name
156161451CV2191854single nucleotide variantNM_030662.4(MAP2K2):c.900C>A (p.Pro300=)RASopathy [RCV003040725]likely benign1940992204099220Human1name
329385305CV2423101single nucleotide variantNM_030662.4(MAP2K2):c.44A>C (p.Asn15Thr)Cardiovascular phenotype [RCV003177074]|RASopathy [RCV005101073]uncertain significance1941238324123832Human1name
329385309CV2423103single nucleotide variantNM_030662.4(MAP2K2):c.567G>A (p.Gln189=)Cardiovascular phenotype [RCV003177076]|RASopathy [RCV003779502]likely benign1941012424101242Human1name
329385310CV2423104single nucleotide variantNM_030662.4(MAP2K2):c.927G>A (p.Gly309=)Cardiovascular phenotype [RCV003177077]likely benign1940973364097336Humanname
11552429CV257128single nucleotide variantNM_030662.4(MAP2K2):c.804C>T (p.Pro268=)RASopathy [RCV002058364]|not specified [RCV000254367]likely benign1940993164099316Human1name
11549189CV257132single nucleotide variantNM_030662.4(MAP2K2):c.516A>G (p.Lys172=)not specified [RCV000250088]likely benign1941023884102388Humanname
401908244CV2815196single nucleotide variantNM_030662.4(MAP2K2):c.70C>G (p.Pro24Ala)not provided [RCV003423210]uncertain significance1941238064123806Humanname
401914186CV2830589single nucleotide variantNM_030662.4(MAP2K2):c.687C>T (p.Gly229=)RASopathy [RCV003539491]|not provided [RCV003442327]uncertain significance1941010374101037Human1name
405158189CV2861765single nucleotide variantNM_030662.4(MAP2K2):c.55G>T (p.Ala19Ser)RASopathy [RCV003539541]uncertain significance1941238214123821Human1name
405160646CV2889582single nucleotide variantNM_030662.4(MAP2K2):c.801C>T (p.Ile267=)RASopathy [RCV003540084]likely benign1940993194099319Human1name
405162069CV2902742single nucleotide variantNM_030662.4(MAP2K2):c.855C>T (p.Asp285=)Cardiovascular phenotype [RCV004369316]|RASopathy [RCV003540201]likely benign1940992654099265Human1name
405163193CV2916224single nucleotide variantNM_030662.4(MAP2K2):c.900C>T (p.Pro300=)RASopathy [RCV003540293]likely benign1940992204099220Human1name
405165204CV2933439single nucleotide variantNM_030662.4(MAP2K2):c.537G>A (p.Arg179=)RASopathy [RCV003540459]likely benign1941012724101272Human1name
405060371CV2999768single nucleotide variantNM_030662.4(MAP2K2):c.61G>C (p.Gly21Arg)RASopathy [RCV003655889]uncertain significance1941238154123815Human1name
405060126CV3002011single nucleotide variantNM_030662.4(MAP2K2):c.513G>A (p.Gly171=)RASopathy [RCV003655868]likely benign1941023914102391Human1name
405047251CV3019887single nucleotide variantNM_030662.4(MAP2K2):c.990T>C (p.Pro330=)RASopathy [RCV003654468]likely benign1940954444095444Human1name
405047114CV3029815single nucleotide variantNM_030662.4(MAP2K2):c.594C>T (p.Ser198=)RASopathy [RCV003654456]uncertain significance1941011304101130Human1name
405047480CV3030385single nucleotide variantNM_030662.4(MAP2K2):c.999G>T (p.Leu333=)RASopathy [RCV003654486]likely benign1940954354095435Human1name
405050709CV3061009single nucleotide variantNM_030662.4(MAP2K2):c.600C>T (p.Ile200=)RASopathy [RCV003654714]likely benign1941011244101124Human1name
405049797CV3066683single nucleotide variantNM_030662.4(MAP2K2):c.528G>C (p.Ala176=)RASopathy [RCV003654667]|not specified [RCV004701807]uncertain significance1941023764102376Human1name
405049813CV3066732single nucleotide variantNM_030662.4(MAP2K2):c.630G>A (p.Leu210=)RASopathy [RCV003654668]likely benign1941010944101094Human1name
405051723CV3069948single nucleotide variantNM_030662.4(MAP2K2):c.543G>A (p.Leu181=)RASopathy [RCV003654793]likely benign1941012664101266Human1name
405052723CV3076763single nucleotide variantNM_030662.4(MAP2K2):c.591C>G (p.Pro197=)RASopathy [RCV003654874]likely benign1941011334101133Human1name
405052370CV3079118single nucleotide variantNM_030662.4(MAP2K2):c.660C>T (p.Ile220=)RASopathy [RCV003654844]likely benign1941010644101064Human1name
405052773CV3079891single nucleotide variantNM_030662.4(MAP2K2):c.363C>G (p.Val121=)RASopathy [RCV003654878]likely benign1941105964110596Human1name
405204276CV3116923single nucleotide variantNM_030662.4(MAP2K2):c.363C>A (p.Val121=)RASopathy [RCV003822407]likely benign1941105964110596Human1name
405112430CV3118542single nucleotide variantNM_030662.4(MAP2K2):c.996G>A (p.Lys332=)RASopathy [RCV003813770]likely benign1940954384095438Human1name
405210758CV3146245single nucleotide variantNM_030662.4(MAP2K2):c.708G>A (p.Pro236=)RASopathy [RCV003845776]likely benign1940994124099412Human1name
405092601CV3164085single nucleotide variantNM_030662.4(MAP2K2):c.97A>C (p.Asn33His)RASopathy [RCV003852400]uncertain significance1941176254117625Human1name
402494836CV3183030single nucleotide variantNM_030662.4(MAP2K2):c.58G>A (p.Glu20Lys)RASopathy [RCV003877338]uncertain significance1941238184123818Human1name
405683296CV3387823single nucleotide variantNM_030662.4(MAP2K2):c.405G>A (p.Gly135=)Cardiovascular phenotype [RCV004517798]|RASopathy [RCV005100635]likely benign1941105544110554Human1name
405683297CV3387824single nucleotide variantNM_030662.4(MAP2K2):c.498C>G (p.Pro166=)Cardiovascular phenotype [RCV004517799]|RASopathy [RCV005100636]likely benign1941024064102406Human1name
405683309CV3387827single nucleotide variantNM_030662.4(MAP2K2):c.91G>A (p.Glu31Lys)Cardiovascular phenotype [RCV004517802]uncertain significance1941237854123785Humanname
407468985CV3446441single nucleotide variantNM_030662.4(MAP2K2):c.336G>C (p.Arg112=)Cardiovascular phenotype [RCV004636472]likely benign1941106234110623Humanname
408374089CV3514322single nucleotide variantNM_030662.4(MAP2K2):c.642G>T (p.Gly214=)MAP2K2-related disorder [RCV004745965]likely benign1941010824101082Humanname , trait , alternate_id
596921484CV3535106single nucleotide variantNM_030662.4(MAP2K2):c.47C>G (p.Pro16Arg)Cardiofaciocutaneous syndrome 4 [RCV005017277]|RASopathy [RCV005105054]|not provided [RCV004784665]uncertain significance1941238294123829Human2name
12741112CV360561deletionNM_030662.4(MAP2K2):c.159del (p.Leu54fs)Cardiofaciocutaneous syndrome 4 [RCV005027472]|RASopathy [RCV001850984]|not provided [RCV000414117]|not specified [RCV001201247]uncertain significance1941175634117563Human2name
597729918CV3699986single nucleotide variantNM_030662.4(MAP2K2):c.852C>T (p.Val284=)Cardiovascular phenotype [RCV004995636]likely benign1940992684099268Humanname
597729920CV3699987single nucleotide variantNM_030662.4(MAP2K2):c.798C>T (p.Pro266=)Cardiovascular phenotype [RCV004995637]likely benign1940993224099322Humanname
597852677CV3737665single nucleotide variantNM_030662.4(MAP2K2):c.77G>A (p.Ser26Asn)RASopathy [RCV005066438]uncertain significance1941237994123799Human1name
597899211CV3774391single nucleotide variantNM_030662.4(MAP2K2):c.81G>T (p.Glu27Asp)RASopathy [RCV005111927]uncertain significance1941237954123795Human1name
597899218CV3774392single nucleotide variantNM_030662.4(MAP2K2):c.62G>T (p.Gly21Val)Cardiovascular phenotype [RCV005365411]|RASopathy [RCV005111928]uncertain significance1941238144123814Human1name
12843853CV377533single nucleotide variantNM_030662.4(MAP2K2):c.327G>A (p.Pro109=)Cardiovascular phenotype [RCV002323589]|RASopathy [RCV002061426]|not provided [RCV000436974]likely benign1941106324110632Human1name
12838956CV377687single nucleotide variantNM_030662.4(MAP2K2):c.813C>T (p.Asp271=)Cardiovascular phenotype [RCV002418252]|RASopathy [RCV000519008]|not provided [RCV000427922]benign|likely benign1940993074099307Human1name
597888682CV3787778single nucleotide variantNM_030662.4(MAP2K2):c.735G>T (p.Ser245=)RASopathy [RCV005125345]likely benign1940993854099385Human1name
597948709CV3801226single nucleotide variantNM_030662.4(MAP2K2):c.612T>A (p.Ser204=)RASopathy [RCV005135406]likely benign1941011124101112Human1name
597882513CV3803143single nucleotide variantNM_030662.4(MAP2K2):c.672C>T (p.Ala224=)RASopathy [RCV005149994]likely benign1941010524101052Human1name
597951709CV3815388single nucleotide variantNM_030662.4(MAP2K2):c.68C>T (p.Ser23Phe)RASopathy [RCV005161338]uncertain significance1941238084123808Human1name
597886388CV3842333single nucleotide variantNM_030662.4(MAP2K2):c.906G>A (p.Gly302=)RASopathy [RCV005178968]likely benign1940992144099214Human1name
597933327CV3844669single nucleotide variantNM_030662.4(MAP2K2):c.37A>T (p.Thr13Ser)RASopathy [RCV005186175]uncertain significance1941238394123839Human1name
597937773CV3852676single nucleotide variantNM_030662.4(MAP2K2):c.534C>T (p.Leu178=)RASopathy [RCV005187075]likely benign1941012754101275Human1name
597932025CV3862448single nucleotide variantNM_030662.4(MAP2K2):c.99C>G (p.Asn33Lys)RASopathy [RCV005206693]uncertain significance1941176234117623Human1name
598196845CV3988648single nucleotide variantNM_030662.4(MAP2K2):c.954C>T (p.Ile318=)Cardiovascular phenotype [RCV005375334]likely benign1940973094097309Humanname
598166179CV3988650single nucleotide variantNM_030662.4(MAP2K2):c.828G>A (p.Glu276=)Cardiovascular phenotype [RCV005369301]likely benign1940992924099292Humanname
12891678CV403254single nucleotide variantNM_030662.4(MAP2K2):c.909C>T (p.Arg303=)Cardiovascular phenotype [RCV002374862]|RASopathy [RCV001419294]likely benign1940992114099211Human1name
12882531CV403727single nucleotide variantNM_030662.4(MAP2K2):c.783C>T (p.Ala261=)Cardiovascular phenotype [RCV002411559]|RASopathy [RCV001494223]likely benign1940993374099337Human1name
13464935CV470250single nucleotide variantNM_030662.4(MAP2K2):c.918C>T (p.Ser306=)Cardiovascular phenotype [RCV003159945]|MAP2K2-related disorder [RCV003900241]|RASopathy [RCV000544637]likely benign|uncertain significance1940992024099202Human2name , trait , alternate_id
13468930CV470924single nucleotide variantNM_030662.4(MAP2K2):c.861A>G (p.Glu287=)RASopathy [RCV000560481]likely benign1940992594099259Human1name
13521516CV488055single nucleotide variantNM_030662.4(MAP2K2):c.399C>T (p.Phe133=)Cardiovascular phenotype [RCV002377219]|RASopathy [RCV002065138]|not specified [RCV000589407]likely benign|uncertain significance1941105604110560Human1name
8609095CV49263single nucleotide variantNM_030662.4(MAP2K2):c.405G>C (p.Gly135=)Cardiofaciocutaneous syndrome 4 [RCV000999815]|Cardiovascular phenotype [RCV002321501]|Noonan syndrome and Noonan-related syndrome [RCV001813312]|RASopathy [RCV000149844]|not provided [RCV001711143]|not specified [RCV000039480]benign1941105544110554Human2name
8609100CV49272single nucleotide variantNM_030662.4(MAP2K2):c.498C>T (p.Pro166=)Cardiovascular phenotype [RCV002336106]|Noonan syndrome and Noonan-related syndrome [RCV001813313]|RASopathy [RCV000458075]|not provided [RCV000726603]|not specified [RCV000039485]benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance1941024064102406Human1name
150477559CV49280single nucleotide variantNM_030662.4(MAP2K2):c.591C>T (p.Pro197=)not provided [RCV001672231]benign1941011334101133Humanname
8609104CV49281single nucleotide variantNM_030662.4(MAP2K2):c.603C>T (p.Leu201=)Cardiovascular phenotype [RCV004018724]|MAP2K2-related disorder [RCV003894846]|Noonan syndrome and Noonan-related syndrome [RCV001813315]|RASopathy [RCV000466681]|not provided [RCV001705635]|not specified [RCV000039489]benign|likely benign1941011214101121Human2name , trait , alternate_id
150515481CV49285single nucleotide variantNM_030662.4(MAP2K2):c.651C>G (p.Gly217=)Cardiovascular phenotype [RCV002360990]|RASopathy [RCV005057537]|not provided [RCV001638845]benign|likely benign1941010734101073Human1name
8609105CV49286single nucleotide variantNM_030662.4(MAP2K2):c.660C>A (p.Ile220=)Cardiofaciocutaneous syndrome 4 [RCV000610143]|Cardiovascular phenotype [RCV002371813]|RASopathy [RCV000149846]|not provided [RCV001705636]|not specified [RCV000039490]benign1941010644101064Human2name
8609109CV49295single nucleotide variantNM_030662.4(MAP2K2):c.823C>T (p.Leu275=)Cardiovascular phenotype [RCV002426540]|MAP2K2-related disorder [RCV003944870]|RASopathy [RCV000520563]|not provided [RCV001705637]|not specified [RCV000039494]benign|likely benign1940992974099297Human2name , trait , alternate_id
8609111CV49297single nucleotide variantNM_030662.4(MAP2K2):c.846C>T (p.Pro282=)Cardiofaciocutaneous syndrome 4 [RCV001000054]|Cardiovascular phenotype [RCV002444458]|Noonan syndrome and Noonan-related syndrome [RCV001813316]|RASopathy [RCV000197348]|not provided [RCV001705638]|not specified [RCV000039496]benign|likely benign1940992744099274Human2name
13491491CV49303single nucleotide variantNM_030662.4(MAP2K2):c.903C>T (p.Pro301=)Cardiovascular phenotype [RCV002371814]|RASopathy [RCV000534262]|not provided [RCV001610308]|not specified [RCV001194170]benign|likely benign1940992174099217Human1name
8609114CV49310single nucleotide variantNM_030662.4(MAP2K2):c.981C>T (p.Asn327=)Cardiovascular phenotype [RCV002371816]|MAP2K2-related disorder [RCV003934877]|RASopathy [RCV001080291]|not provided [RCV000590665]|not specified [RCV000039499]benign|likely benign1940972824097282Human2name , trait , alternate_id
13518456CV494978single nucleotide variantNM_030662.4(MAP2K2):c.32C>G (p.Ala11Gly)not specified [RCV000597450]uncertain significance1941238444123844Humanname
13528780CV497521single nucleotide variantNM_030662.4(MAP2K2):c.834C>A (p.Ile278=)not specified [RCV000605554]likely benign1940992864099286Humanname
13537195CV506828single nucleotide variantNM_030662.4(MAP2K2):c.894G>A (p.Pro298=)Cardiovascular phenotype [RCV002448902]|MAP2K2-related disorder [RCV003892378]|RASopathy [RCV002066693]|not provided [RCV005427163]|not specified [RCV000610061]likely benign1940992264099226Human2name , trait , alternate_id
13538184CV506831single nucleotide variantNM_030662.4(MAP2K2):c.456C>T (p.Gly152=)Cardiovascular phenotype [RCV003302944]|RASopathy [RCV001054943]|not provided [RCV003884662]|not specified [RCV000611453]benign|likely benign|uncertain significance1941024484102448Human1name
13536725CV507397single nucleotide variantNM_030662.4(MAP2K2):c.351C>G (p.Arg117=)Cardiovascular phenotype [RCV002457954]|Noonan syndrome and Noonan-related syndrome [RCV001813526]|RASopathy [RCV005091733]|not provided [RCV001719079]likely benign|uncertain significance1941106084110608Human1name
13626613CV533110single nucleotide variantNM_030662.4(MAP2K2):c.390C>T (p.Ile130=)Cardiovascular phenotype [RCV002369767]|RASopathy [RCV000655014]|not specified [RCV001193490]likely benign1941105694110569Human1name
13626550CV533548single nucleotide variantNM_030662.4(MAP2K2):c.477G>A (p.Leu159=)Cardiovascular phenotype [RCV003303081]|RASopathy [RCV002534223]|not specified [RCV001797772]likely benign1941024274102427Human1name
13626541CV533554single nucleotide variantNM_030662.4(MAP2K2):c.402C>T (p.Tyr134=)Cardiovascular phenotype [RCV002358898]|MAP2K2-related disorder [RCV003945685]|RASopathy [RCV000654985]likely benign1941105574110557Human2name , trait , alternate_id
13796746CV553031deletionNM_030662.4(MAP2K2):c.1046+91_1046+92delnot provided [RCV000680732]likely benign1940952964095297Humanname
8609096CV55400single nucleotide variantNM_030662.4(MAP2K2):c.420C>T (p.Asp140=)Cardiovascular phenotype [RCV002326746]|Noonan syndrome and Noonan-related syndrome [RCV001813365]|RASopathy [RCV000521680]|not provided [RCV000587230]|not specified [RCV000039481]benign|likely benign1941105394110539Human1name
8609099CV55402single nucleotide variantNM_030662.4(MAP2K2):c.453C>T (p.Asp151=)Cardiofaciocutaneous syndrome 4 [RCV001001539]|Cardiovascular phenotype [RCV002326747]|RASopathy [RCV000149845]|not provided [RCV000509111]|not specified [RCV000039484]benign|not provided1941024514102451Human2name
8609101CV55403single nucleotide variantNM_030662.4(MAP2K2):c.49A>G (p.Thr17Ala)not provided [RCV001564919]|not specified [RCV000039486]likely benign|uncertain significance1941238274123827Humanname
8609102CV55404single nucleotide variantNM_030662.4(MAP2K2):c.525C>T (p.Ile175=)Cardiovascular phenotype [RCV002336140]|Noonan syndrome and Noonan-related syndrome [RCV001813366]|RASopathy [RCV000126671]|not specified [RCV000039487]benign|likely benign|conflicting interpretations of pathogenicity1941023794102379Human1name
8609106CV55405single nucleotide variantNM_030662.4(MAP2K2):c.678C>T (p.Ser226=)Cardiovascular phenotype [RCV002362632]|RASopathy [RCV000654987]|not provided [RCV003237418]|not specified [RCV000039491]benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance1941010464101046Human1name
8609113CV55408single nucleotide variantNM_030662.4(MAP2K2):c.939G>T (p.Arg313=)Cardiovascular phenotype [RCV003162346]|RASopathy [RCV000862266]|not specified [RCV000039498]likely benign1940973244097324Human1name
14396243CV612027single nucleotide variantNM_030662.4(MAP2K2):c.46C>A (p.Pro16Thr)Cardiofaciocutaneous syndrome 4 [RCV005021149]|Noonan syndrome [RCV000761005]|RASopathy [RCV002533858]uncertain significance1941238304123830Human3name
14689796CV621634single nucleotide variantNM_030662.4(MAP2K2):c.699C>T (p.Tyr233=)Cardiovascular phenotype [RCV004027317]|RASopathy [RCV002536864]|not specified [RCV000780393]likely benign|uncertain significance1941010254101025Human1name
14689807CV621635single nucleotide variantNM_030662.4(MAP2K2):c.531T>C (p.Val177=)Cardiovascular phenotype [RCV004994003]|RASopathy [RCV003655209]|not specified [RCV000780397]likely benign|uncertain significance1941012784101278Human1name
14689799CV621636single nucleotide variantNM_030662.4(MAP2K2):c.357G>A (p.Leu119=)RASopathy [RCV003768453]|not specified [RCV000780394]likely benign|uncertain significance1941106024110602Human1name
8611994CV65600single nucleotide variantNM_030662.4(MAP2K2):c.474G>A (p.Val158=)Cardiovascular phenotype [RCV002336167]|RASopathy [RCV002054865]|not provided [RCV000680359]|not specified [RCV000043644]likely benign1941024304102430Human1name
8611995CV65601single nucleotide variantNM_030662.4(MAP2K2):c.621G>A (p.Glu207=)Cardiovascular phenotype [RCV003298088]|MAP2K2-related disorder [RCV003894883]|RASopathy [RCV001412978]|not provided [RCV004703198]|not specified [RCV000043645]benign|likely benign|conflicting interpretations of pathogenicity1941011034101103Human2name , trait , alternate_id
15149389CV689062single nucleotide variantNM_030662.4(MAP2K2):c.681C>T (p.Phe227=)RASopathy [RCV000866848]likely benign1941010434101043Human1name
15152732CV689063single nucleotide variantNM_030662.4(MAP2K2):c.429C>T (p.Ile143=)Cardiovascular phenotype [RCV002332801]|RASopathy [RCV001416962]likely benign1941105304110530Human1name
15107953CV694425single nucleotide variantNM_030662.4(MAP2K2):c.778C>T (p.Leu260=)RASopathy [RCV005092597]likely benign1940993424099342Human1name
15116940CV694426single nucleotide variantNM_030662.4(MAP2K2):c.534C>G (p.Leu178=)RASopathy [RCV000873415]|not specified [RCV001251360]benign|likely benign1941012754101275Human1name
15203306CV757038single nucleotide variantNM_030662.4(MAP2K2):c.315T>G (p.Leu105=)RASopathy [RCV001430524]|not provided [RCV003424468]likely benign1941106444110644Human1name
34896170CV917295single nucleotide variantNM_030662.4(MAP2K2):c.990T>A (p.Pro330=)not specified [RCV001193491]likely benign1940954444095444Humanname
34896167CV917296single nucleotide variantNM_030662.4(MAP2K2):c.987A>G (p.Pro329=)not specified [RCV001193487]uncertain significance1940954474095447Humanname
42723989CV984001single nucleotide variantNM_030662.4(MAP2K2):c.750C>T (p.Ile250=)not specified [RCV001290623]likely benign1940993704099370Humanname
126753733CV998618single nucleotide variantNM_030662.4(MAP2K2):c.34C>A (p.Leu12Ile)RASopathy [RCV001307458]uncertain significance1941238424123842Human1name
150528988CV1288599single nucleotide variantNM_030662.4(MAP2K2):c.260C>A (p.Thr87Asn)not provided [RCV001727067]uncertain significance1941174624117462Humanname
150553566CV1303575single nucleotide variantNM_030662.4(MAP2K2):c.250G>A (p.Gly84Arg)not provided [RCV001769265]uncertain significance1941174724117472Humanname
151352162CV1325120single nucleotide variantNM_030662.4(MAP2K2):c.284G>A (p.Gly95Asp)Noonan syndrome and Noonan-related syndrome [RCV001813676]uncertain significance1941174384117438Humanname
151767790CV1348760deletionNM_030662.4(MAP2K2):c.639del (p.Phe213fs)RASopathy [RCV001896035]uncertain significance1941010854101085Human1name
151764785CV1362398duplicationNM_030662.4(MAP2K2):c.608dup (p.Asn203fs)RASopathy [RCV001970588]uncertain significance1941011154101116Human1name
151804578CV1362940single nucleotide variantNM_030662.4(MAP2K2):c.238G>A (p.Ala80Thr)RASopathy [RCV002028406]|not provided [RCV002225958]likely benign|uncertain significance1941174844117484Human1name
151849091CV1402951single nucleotide variantNM_030662.4(MAP2K2):c.292A>G (p.Met98Val)Cardiovascular phenotype [RCV004041478]|RASopathy [RCV001882357]uncertain significance1941174304117430Human1name
151727421CV1412690single nucleotide variantNM_030662.4(MAP2K2):c.214T>G (p.Phe72Val)RASopathy [RCV001945701]uncertain significance1941175084117508Human1name
8691898CV141865single nucleotide variantNM_030662.4(MAP2K2):c.1005C>T (p.Asn335=)Cardiovascular phenotype [RCV002408633]|Noonan syndrome and Noonan-related syndrome [RCV001813387]|RASopathy [RCV003654206]|not specified [RCV000126679]benign|likely benign|uncertain significance1940954294095429Human1name
151884741CV1424995single nucleotide variantNM_030662.4(MAP2K2):c.1074G>C (p.Ala358=)Cardiovascular phenotype [RCV002422994]|RASopathy [RCV001887210]|not provided [RCV005242123]likely benign1940944714094471Human1name
152159032CV1529174single nucleotide variantNM_030662.4(MAP2K2):c.1101C>G (p.Thr367=)RASopathy [RCV002159303]likely benign1940907004090700Human1name
152052814CV1607296single nucleotide variantNM_030662.4(MAP2K2):c.1053C>T (p.Ile351=)RASopathy [RCV002109190]likely benign1940944924094492Human1name
152100044CV1610765single nucleotide variantNM_030662.4(MAP2K2):c.1116C>T (p.Ser372=)RASopathy [RCV002133158]likely benign1940906854090685Human1name
152039718CV1643991single nucleotide variantNM_030662.4(MAP2K2):c.1159C>T (p.Leu387=)RASopathy [RCV002125906]likely benign1940906424090642Human1name
9691802CV176174single nucleotide variantNM_030662.4(MAP2K2):c.169T>A (p.Phe57Ile)not specified [RCV000151011]uncertain significance1941175534117553Humanname
155697513CV1790350single nucleotide variantNM_030662.4(MAP2K2):c.1162C>A (p.Arg388=)Cardiovascular phenotype [RCV002375740]likely benign1940906394090639Humanname
155681641CV1795614single nucleotide variantNM_030662.4(MAP2K2):c.1011G>A (p.Val337=)Cardiovascular phenotype [RCV002456918]likely benign1940954234095423Humanname
9832812CV179827single nucleotide variantNM_030662.4(MAP2K2):c.190G>T (p.Val64Phe)RASopathy [RCV003539802]|not provided [RCV000158040]likely pathogenic1941175324117532Human1name
9832810CV179828single nucleotide variantNM_030662.4(MAP2K2):c.169T>C (p.Phe57Leu)Cardiofaciocutaneous syndrome 4 [RCV004796053]|RASopathy [RCV003447507]|not provided [RCV000158037]pathogenic|likely pathogenic1941175534117553Human2name
155667883CV1799804single nucleotide variantNM_030662.4(MAP2K2):c.1017C>T (p.Thr339=)Cardiofaciocutaneous syndrome 4 [RCV005025801]|Cardiovascular phenotype [RCV002349558]likely benign|uncertain significance1940954174095417Human1name
155672574CV1809182single nucleotide variantNM_030662.4(MAP2K2):c.118A>C (p.Lys40Gln)Cardiovascular phenotype [RCV002351333]uncertain significance1941176044117604Humanname
155694815CV1844484single nucleotide variantNM_030662.4(MAP2K2):c.1089C>G (p.Leu363=)Cardiovascular phenotype [RCV002443532]likely benign1940944564094456Humanname
155686822CV1852715single nucleotide variantNM_030662.4(MAP2K2):c.1116C>G (p.Ser372=)Cardiovascular phenotype [RCV002441654]likely benign1940906854090685Humanname
156155306CV1931394single nucleotide variantNM_030662.4(MAP2K2):c.193G>A (p.Gly65Ser)RASopathy [RCV002664043]uncertain significance1941175294117529Human1name
156208217CV1932192single nucleotide variantNM_030662.4(MAP2K2):c.256G>A (p.Val86Ile)RASopathy [RCV002643893]uncertain significance1941174664117466Human1name
156159810CV1977743single nucleotide variantNM_030662.4(MAP2K2):c.245A>G (p.Asn82Ser)RASopathy [RCV002594425]uncertain significance1941174774117477Human1name
156415770CV1987503single nucleotide variantNM_030662.4(MAP2K2):c.178C>T (p.Gln60Ter)RASopathy [RCV002609826]uncertain significance1941175444117544Human1name
156029444CV2036792single nucleotide variantNM_030662.4(MAP2K2):c.1165C>T (p.Leu389=)RASopathy [RCV002781048]likely benign1940906364090636Human1name
156079487CV2053786single nucleotide variantNM_030662.4(MAP2K2):c.238G>T (p.Ala80Ser)RASopathy [RCV002823806]uncertain significance1941174844117484Human1name
156100819CV2107387single nucleotide variantNM_030662.4(MAP2K2):c.158G>A (p.Arg53Gln)RASopathy [RCV002927045]|not provided [RCV004779379]likely pathogenic|uncertain significance1941175644117564Human1name
156025263CV2112414single nucleotide variantNM_030662.4(MAP2K2):c.1188G>A (p.Thr396=)RASopathy [RCV002909807]likely benign1940906134090613Human1name
155992108CV2147640single nucleotide variantNM_030662.4(MAP2K2):c.209A>G (p.Asp70Gly)RASopathy [RCV003016875]uncertain significance1941175134117513Human1name
156330555CV2224284single nucleotide variantNM_030662.4(MAP2K2):c.191T>C (p.Val64Ala)Cardiovascular phenotype [RCV004096105]uncertain significance1941175314117531Humanname
8560417CV23311single nucleotide variantNM_030662.4(MAP2K2):c.170T>G (p.Phe57Cys)Cardio-facio-cutaneous syndrome [RCV000208756]|Cardiofaciocutaneous syndrome 4 [RCV000008761]|RASopathy [RCV005252030]|not provided [RCV000158038]pathogenic|not provided1941175524117552Human3name
8560418CV23312single nucleotide variantNM_030662.4(MAP2K2):c.169T>G (p.Phe57Val)Cardio-facio-cutaneous syndrome [RCV000521375]|Cardiofaciocutaneous syndrome 4 [RCV000008762]pathogenic|likely pathogenic1941175534117553Human2name
243052568CV2417931single nucleotide variantNM_030662.4(MAP2K2):c.167C>A (p.Ala56Asp)Cardiofaciocutaneous syndrome 4 [RCV003152996]likely pathogenic1941175554117555Human1name
11552194CV257127single nucleotide variantNM_030662.4(MAP2K2):c.1074G>A (p.Ala358=)Cardiovascular phenotype [RCV002418088]|RASopathy [RCV000470994]|not specified [RCV000254049]benign|likely benign1940944714094471Human1name
11633349CV264851single nucleotide variantNM_030662.4(MAP2K2):c.183A>C (p.Lys61Asn)Cardiofaciocutaneous syndrome 4 [RCV001775109]|RASopathy [RCV001855055]|not provided [RCV000330980]pathogenic|likely pathogenic1941175394117539Human2name
329951992CV2668740single nucleotide variantNM_030662.4(MAP2K2):c.208G>A (p.Asp70Asn)RASopathy [RCV003655412]|not specified [RCV003230821]uncertain significance1941175144117514Human1name
401932132CV2801605single nucleotide variantNM_030662.4(MAP2K2):c.277C>A (p.Pro93Thr)MAP2K2-related disorder [RCV003408493]uncertain significance1941174454117445Humanname , trait , alternate_id
401905431CV2831461duplicationNM_030662.4(MAP2K2):c.903dup (p.Gly302fs)Cardiofaciocutaneous syndrome 4 [RCV003444453]|RASopathy [RCV003539492]uncertain significance1940992164099217Human2name
405160483CV2882452single nucleotide variantNM_030662.4(MAP2K2):c.1158C>T (p.Thr386=)RASopathy [RCV003540068]likely benign1940906434090643Human1name
405160841CV2883025single nucleotide variantNM_030662.4(MAP2K2):c.205G>C (p.Asp69His)Cardiovascular phenotype [RCV004992647]|RASopathy [RCV003540100]uncertain significance1941175174117517Human1name
405160739CV2886450deletionNM_030662.4(MAP2K2):c.903del (p.Arg303fs)RASopathy [RCV003540092]uncertain significance1940992174099217Human1name
405165495CV2911420single nucleotide variantNM_030662.4(MAP2K2):c.110T>A (p.Leu37Gln)Cardiovascular phenotype [RCV004369442]|RASopathy [RCV003540370]uncertain significance1941176124117612Human1name
405162982CV2915856single nucleotide variantNM_030662.4(MAP2K2):c.188A>C (p.Lys63Thr)RASopathy [RCV003540276]uncertain significance1941175344117534Human1name
405054499CV2946649single nucleotide variantNM_030662.4(MAP2K2):c.157C>T (p.Arg53Trp)RASopathy [RCV003655450]uncertain significance1941175654117565Human1name
405057856CV2970060single nucleotide variantNM_030662.4(MAP2K2):c.166G>A (p.Ala56Thr)RASopathy [RCV003655714]uncertain significance1941175564117556Human1name
405059666CV2998579duplicationNM_030662.4(MAP2K2):c.567dup (p.Ile190fs)RASopathy [RCV003655856]uncertain significance1941012414101242Human1name
405050186CV3039020single nucleotide variantNM_030662.4(MAP2K2):c.270G>T (p.Gln90His)RASopathy [RCV003654540]uncertain significance1941174524117452Human1name
405048872CV3043710single nucleotide variantNM_030662.4(MAP2K2):c.1050C>T (p.Leu350=)Cardiovascular phenotype [RCV004634333]|RASopathy [RCV003654595]likely benign1940944954094495Human1name
405051759CV3066103single nucleotide variantNM_030662.4(MAP2K2):c.1041T>C (p.Asn347=)RASopathy [RCV003654796]likely benign1940953934095393Human1name
405094062CV3134691single nucleotide variantNM_030662.4(MAP2K2):c.1197C>G (p.Ala399=)RASopathy [RCV003835037]|not provided [RCV004585069]likely benign1940906044090604Human1name
405156954CV3152551single nucleotide variantNM_030662.4(MAP2K2):c.185C>T (p.Ala62Val)RASopathy [RCV003840478]uncertain significance1941175374117537Human1name
407425478CV3411272single nucleotide variantNM_030662.4(MAP2K2):c.260C>T (p.Thr87Ile)RASopathy [RCV005102002]|not provided [RCV004588963]uncertain significance1941174624117462Human1name
408378686CV3505283single nucleotide variantNM_030662.4(MAP2K2):c.211G>A (p.Asp71Asn)MAP2K2-related disorder [RCV004727990]uncertain significance1941175114117511Humanname , trait , alternate_id
408374770CV3507281single nucleotide variantNM_030662.4(MAP2K2):c.1191C>A (p.Arg397=)MAP2K2-related disorder [RCV004747465]likely benign1940906104090610Humanname , trait , alternate_id
408390219CV3519259single nucleotide variantNM_030662.4(MAP2K2):c.146A>C (p.Gln49Pro)not provided [RCV004762568]uncertain significance1941175764117576Humanname
596923380CV3530364single nucleotide variantNM_030662.4(MAP2K2):c.209A>T (p.Asp70Val)not provided [RCV004776963]uncertain significance1941175134117513Humanname
12741062CV360427single nucleotide variantNM_030662.4(MAP2K2):c.216C>G (p.Phe72Leu)not specified [RCV000413956]uncertain significance1941175064117506Humanname
12740744CV360436single nucleotide variantNM_030662.4(MAP2K2):c.247G>A (p.Gly83Ser)Cardiofaciocutaneous syndrome 4 [RCV002502442]|RASopathy [RCV001850988]|not provided [RCV002223837]|not specified [RCV000412991]uncertain significance1941174754117475Human2name
12835226CV363057single nucleotide variantNM_030662.4(MAP2K2):c.179A>C (p.Gln60Pro)Melanoma [RCV000421323]likely pathogenic1941175434117543Human1name
12841116CV363058single nucleotide variantNM_030662.4(MAP2K2):c.136C>T (p.Leu46Phe)Melanoma [RCV000432005]likely pathogenic1941175864117586Human1name
12847769CV363059single nucleotide variantNM_030662.4(MAP2K2):c.103G>A (p.Val35Met)Melanoma [RCV000444084]likely pathogenic1941176194117619Human1name
12834325CV363328single nucleotide variantNM_030662.4(MAP2K2):c.171T>G (p.Phe57Leu)Gastric adenocarcinoma [RCV000438529]|Malignant melanoma of skin [RCV000417753]|Pancreatic adenocarcinoma [RCV000428429]|Squamous cell carcinoma of the head and neck [RCV000429600]likely pathogenic1941175514117551Human3name
597729911CV3699984single nucleotide variantNM_030662.4(MAP2K2):c.1164G>A (p.Arg388=)Cardiovascular phenotype [RCV004995634]likely benign1940906374090637Humanname
597662549CV3709759single nucleotide variantNM_030662.4(MAP2K2):c.251G>T (p.Gly84Val)Cardiofaciocutaneous syndrome 4 [RCV005028652]uncertain significance1941174714117471Human1name
597750981CV3709760single nucleotide variantNM_030662.4(MAP2K2):c.176C>G (p.Thr59Ser)Cardiofaciocutaneous syndrome 4 [RCV005015761]uncertain significance1941175464117546Human1name
597849022CV3762290single nucleotide variantNM_030662.4(MAP2K2):c.151A>C (p.Lys51Gln)not specified [RCV005087710]uncertain significance1941175714117571Humanname
597899194CV3774388single nucleotide variantNM_030662.4(MAP2K2):c.286C>G (p.Leu96Val)RASopathy [RCV005111924]uncertain significance1941174364117436Human1name
597899200CV3774389single nucleotide variantNM_030662.4(MAP2K2):c.283G>C (p.Gly95Arg)RASopathy [RCV005111925]uncertain significance1941174394117439Human1name
597899204CV3774390single nucleotide variantNM_030662.4(MAP2K2):c.142G>C (p.Glu48Gln)RASopathy [RCV005111926]uncertain significance1941175804117580Human1name
597878793CV3783163single nucleotide variantNM_030662.4(MAP2K2):c.1074G>T (p.Ala358=)RASopathy [RCV005123865]likely benign1940944714094471Human1name
597951679CV3798395single nucleotide variantNM_030662.4(MAP2K2):c.1068G>A (p.Glu356=)RASopathy [RCV005136175]likely benign1940944774094477Human1name
597929396CV3862866single nucleotide variantNM_030662.4(MAP2K2):c.207C>A (p.Asp69Glu)RASopathy [RCV005206400]uncertain significance1941175154117515Human1name
598127643CV3888267single nucleotide variantNM_030662.4(MAP2K2):c.280T>C (p.Ser94Pro)not provided [RCV005242953]uncertain significance1941174424117442Humanname
12899800CV410619single nucleotide variantNM_030662.4(MAP2K2):c.143A>G (p.Glu48Gly)RASopathy [RCV005090926]|not provided [RCV000480980]uncertain significance1941175794117579Human1name
13210994CV424697single nucleotide variantNM_030662.4(MAP2K2):c.191T>G (p.Val64Gly)Cardiofaciocutaneous syndrome 4 [RCV000496536]likely pathogenic1941175314117531Human1name
13520331CV487815single nucleotide variantNM_030662.4(MAP2K2):c.170T>A (p.Phe57Tyr)not provided [RCV000587607]uncertain significance1941175524117552Humanname
13519944CV488001single nucleotide variantNM_030662.4(MAP2K2):c.1176C>T (p.Pro392=)Cardiovascular phenotype [RCV003160002]|Noonan syndrome and Noonan-related syndrome [RCV001813513]|RASopathy [RCV001486600]|not provided [RCV001706681]|not specified [RCV000604668]likely benign|uncertain significance1940906254090625Human1name
13520251CV488049single nucleotide variantNM_030662.4(MAP2K2):c.1197C>T (p.Ala399=)Cardiovascular phenotype [RCV002341507]|RASopathy [RCV001442973]|not specified [RCV000608972]likely benign|uncertain significance1940906044090604Human1name
9832811CV49239single nucleotide variantNM_030662.4(MAP2K2):c.181A>G (p.Lys61Glu)Cardiofaciocutaneous syndrome 1 [RCV000200295]|Cardiofaciocutaneous syndrome 4 [RCV001781338]|RASopathy [RCV001205317]|not provided [RCV000158039]pathogenic|likely pathogenic1941175414117541Human3name
9832813CV49241single nucleotide variantNM_030662.4(MAP2K2):c.253G>T (p.Val85Leu)not provided [RCV000158041]uncertain significance1941174694117469Humanname
12740751CV49242single nucleotide variantNM_030662.4(MAP2K2):c.274A>G (p.Arg92Gly)Cardiovascular phenotype [RCV003162290]|Neurofibromatosis-Noonan syndrome [RCV000824945]|RASopathy [RCV001063339]|not provided [RCV003153319]|not specified [RCV000413006]likely benign|conflicting interpretations of pathogenicity|uncertain significance1941174484117448Human2name
9689127CV49256single nucleotide variantNM_030662.4(MAP2K2):c.281C>T (p.Ser94Leu)Cardiofaciocutaneous syndrome 4 [RCV003129758]|Cardiovascular phenotype [RCV004991982]|RASopathy [RCV000521587]|not provided [RCV000767152]|not specified [RCV000154558]likely benign|conflicting interpretations of pathogenicity|uncertain significance1941174414117441Human2name
11637436CV49258single nucleotide variantNM_030662.4(MAP2K2):c.291C>G (p.Ile97Met)RASopathy [RCV002513331]|not provided [RCV000285952]|not specified [RCV003488354]likely benign|uncertain significance1941174314117431Human1name
8609087CV49316single nucleotide variantNM_030662.4(MAP2K2):c.1194C>T (p.Thr398=)Cardiovascular phenotype [RCV002336107]|RASopathy [RCV000205301]|not provided [RCV000590246]|not specified [RCV000039472]benign|likely benign1940906074090607Human1name
13526091CV497522single nucleotide variantNM_030662.4(MAP2K2):c.183A>T (p.Lys61Asn)Noonan syndrome 1 [RCV003451363]|Noonan syndrome with multiple lentigines [RCV000824943]|not provided [RCV004722970]|not specified [RCV000603653]likely pathogenic|uncertain significance1941175394117539Human2name
13540084CV506826single nucleotide variantNM_030662.4(MAP2K2):c.1167G>A (p.Leu389=)Cardiovascular phenotype [RCV002331061]|RASopathy [RCV005091678]|not specified [RCV000614207]likely benign1940906344090634Human1name
13535332CV507820single nucleotide variantNM_030662.4(MAP2K2):c.1092A>G (p.Thr364=)not specified [RCV000602266]likely benign1940944534094453Humanname
13626505CV533051single nucleotide variantNM_030662.4(MAP2K2):c.217G>A (p.Glu73Lys)Cardiofaciocutaneous syndrome 4 [RCV002485483]|Cardiovascular phenotype [RCV002424552]|RASopathy [RCV000654927]uncertain significance1941175054117505Human2name
13796556CV553043single nucleotide variantNM_030662.4(MAP2K2):c.198A>T (p.Glu66Asp)not provided [RCV000680643]uncertain significance1941175244117524Humanname
8609084CV55391single nucleotide variantNM_030662.4(MAP2K2):c.1020C>T (p.Pro340=)Cardiovascular phenotype [RCV002381315]|MAP2K2-related disorder [RCV003944927]|Noonan syndrome and Noonan-related syndrome [RCV001813364]|RASopathy [RCV000233235]|not provided [RCV003415776]|not specified [RCV000039469]benign|likely benign1940954144095414Human2name , trait , alternate_id
8609085CV55392single nucleotide variantNM_030662.4(MAP2K2):c.1065G>A (p.Ala355=)Cardiovascular phenotype [RCV002408525]|RASopathy [RCV001088940]|not provided [RCV000680295]|not specified [RCV000039470]benign|likely benign|conflicting interpretations of pathogenicity1940944804094480Human1name
8609092CV55397single nucleotide variantNM_030662.4(MAP2K2):c.289A>T (p.Ile97Phe)RASopathy [RCV000545526]|not provided [RCV000767153]|not specified [RCV000039477]uncertain significance1941174334117433Human1name
13809442CV574980single nucleotide variantNM_030662.4(MAP2K2):c.171T>A (p.Phe57Leu)RASopathy [RCV000702132]pathogenic|uncertain significance1941175514117551Human1name
14689804CV621633single nucleotide variantNM_030662.4(MAP2K2):c.1092A>C (p.Thr364=)Cardiofaciocutaneous syndrome 4 [RCV005021168]|Noonan syndrome and Noonan-related syndrome [RCV001813551]|RASopathy [RCV001856185]|not specified [RCV000780396]uncertain significance1940944534094453Human2name
14702884CV653985single nucleotide variantNM_030662.4(MAP2K2):c.149A>G (p.Gln50Arg)Noonan syndrome [RCV000824942]likely benign1941175734117573Human1name
8611993CV65599single nucleotide variantNM_030662.4(MAP2K2):c.1140C>T (p.Ala380=)Cardiovascular phenotype [RCV002460041]|MAP2K2-related disorder [RCV003944960]|Noonan syndrome and Noonan-related syndrome [RCV001813371]|RASopathy [RCV000521790]|not specified [RCV000043643]benign|likely benign|conflicting interpretations of pathogenicity1940906614090661Human2name , trait , alternate_id
15133361CV684819single nucleotide variantNM_030662.4(MAP2K2):c.1191C>T (p.Arg397=)Cardiovascular phenotype [RCV002336765]|RASopathy [RCV000863950]|not provided [RCV001593076]|not specified [RCV001193489]likely benign1940906104090610Human1name
34896168CV917294single nucleotide variantNM_030662.4(MAP2K2):c.1080G>A (p.Leu360=)RASopathy [RCV005094026]|not specified [RCV001193488]likely benign1940944654094465Human1name
38473525CV950802single nucleotide variantNM_030662.4(MAP2K2):c.239C>T (p.Ala80Val)RASopathy [RCV001231849]uncertain significance1941174834117483Human1name
42723988CV984000single nucleotide variantNM_030662.4(MAP2K2):c.1182A>G (p.Thr394=)Cardiovascular phenotype [RCV002327627]|RASopathy [RCV001422838]|not provided [RCV001587321]|not specified [RCV001290622]likely benign1940906194090619Human1name
126749237CV998617single nucleotide variantNM_030662.4(MAP2K2):c.154A>C (p.Lys52Gln)RASopathy [RCV001306589]|not specified [RCV004699293]likely pathogenic|likely benign|uncertain significance1941175684117568Human1name
126733318CV1021896single nucleotide variantNM_030662.4(MAP2K2):c.300G>T (p.Arg100Ser)Cardiofaciocutaneous syndrome 4 [RCV001334285]uncertain significance1941174224117422Human1name
126760887CV1034319deletionNM_030662.4(MAP2K2):c.1185del (p.Thr396fs)RASopathy [RCV001340534]uncertain significance1940906164090616Human1name
126743754CV1034320single nucleotide variantNM_030662.4(MAP2K2):c.794A>T (p.Tyr265Phe)RASopathy [RCV001351187]uncertain significance1940993264099326Human1name
126748659CV1034321single nucleotide variantNM_030662.4(MAP2K2):c.604G>T (p.Val202Leu)RASopathy [RCV001337694]uncertain significance1941011204101120Human1name
126733187CV1034322single nucleotide variantNM_030662.4(MAP2K2):c.515A>G (p.Lys172Arg)RASopathy [RCV001349733]uncertain significance1941023894102389Human1name
126733608CV1034323single nucleotide variantNM_030662.4(MAP2K2):c.358C>G (p.Gln120Glu)RASopathy [RCV001349809]uncertain significance1941106014110601Human1name
127283927CV1084742single nucleotide variantNM_030662.4(MAP2K2):c.813C>G (p.Asp271Glu)Cardiovascular phenotype [RCV002420923]|RASopathy [RCV001412095]|not specified [RCV001806170]likely benign|uncertain significance1940993074099307Human1name
150413126CV1178385single nucleotide variantNM_030662.4(MAP2K2):c.974T>C (p.Ile325Thr)not provided [RCV001547701]uncertain significance1940972894097289Humanname
150435327CV1244388single nucleotide variantNM_030662.4(MAP2K2):c.928A>G (p.Met310Val)RASopathy [RCV002539609]|not provided [RCV001665379]uncertain significance1940973354097335Human1name
150528986CV1288598single nucleotide variantNM_030662.4(MAP2K2):c.764T>C (p.Leu255Pro)not provided [RCV001727066]likely benign|uncertain significance1940993564099356Humanname
150555859CV1305351single nucleotide variantNM_030662.4(MAP2K2):c.479A>G (p.Lys160Arg)not provided [RCV001773284]uncertain significance1941024254102425Humanname
151236110CV1319541single nucleotide variantNM_030662.4(MAP2K2):c.908G>T (p.Arg303Leu)not provided [RCV001797486]uncertain significance1940992124099212Humanname
151351631CV1321878single nucleotide variantNM_030662.4(MAP2K2):c.743C>T (p.Ser248Leu)Cardiofaciocutaneous syndrome 4 [RCV005014672]|RASopathy [RCV002541377]|not provided [RCV001806548]uncertain significance1940993774099377Human2name
151352157CV1325116single nucleotide variantNM_030662.4(MAP2K2):c.969C>G (p.Asp323Glu)Cardiofaciocutaneous syndrome 4 [RCV002482343]|Cardiovascular phenotype [RCV002386574]|Noonan syndrome and Noonan-related syndrome [RCV001813672]|RASopathy [RCV005095227]uncertain significance1940972944097294Human2name
151352160CV1325118single nucleotide variantNM_030662.4(MAP2K2):c.907C>T (p.Arg303Cys)Cardiofaciocutaneous syndrome 4 [RCV003992562]|Noonan syndrome and Noonan-related syndrome [RCV001813674]|RASopathy [RCV001869617]uncertain significance1940992134099213Human2name
151771010CV1340184single nucleotide variantNM_030662.4(MAP2K2):c.703G>T (p.Ala235Ser)RASopathy [RCV001874448]uncertain significance1941010214101021Human1name
151845726CV1341842single nucleotide variantNM_030662.4(MAP2K2):c.908G>A (p.Arg303His)Cardiovascular phenotype [RCV002370436]|RASopathy [RCV001922086]uncertain significance1940992124099212Human1name
151784711CV1344727single nucleotide variantNM_030662.4(MAP2K2):c.919G>A (p.Gly307Ser)RASopathy [RCV001989454]uncertain significance1940992014099201Human1name
151804462CV1362883single nucleotide variantNM_030662.4(MAP2K2):c.395G>T (p.Gly132Val)RASopathy [RCV002028395]likely pathogenic1941105644110564Human1name
151838309CV1382730single nucleotide variantNM_030662.4(MAP2K2):c.349C>T (p.Arg117Cys)RASopathy [RCV002031522]uncertain significance1941106104110610Human1name
151714679CV1388662single nucleotide variantNM_030662.4(MAP2K2):c.836T>C (p.Phe279Ser)RASopathy [RCV002002697]uncertain significance1940992844099284Human1name
151711414CV1395059single nucleotide variantNM_030662.4(MAP2K2):c.457G>A (p.Gly153Ser)Cardiofaciocutaneous syndrome 4 [RCV005025556]|Cardiovascular phenotype [RCV004631879]|RASopathy [RCV001964375]uncertain significance1941024474102447Human2name
151859344CV1403527single nucleotide variantNM_030662.4(MAP2K2):c.388A>G (p.Ile130Val)Cardiovascular phenotype [RCV004043833]|RASopathy [RCV001979923]uncertain significance1941105714110571Human1name
151775332CV1424250single nucleotide variantNM_030662.4(MAP2K2):c.872C>T (p.Pro291Leu)Cardiovascular phenotype [RCV003303622]|RASopathy [RCV002025754]uncertain significance1940992484099248Human1name
151709996CV1433497single nucleotide variantNM_030662.4(MAP2K2):c.499G>A (p.Glu167Lys)RASopathy [RCV002001757]uncertain significance1941024054102405Human1name
151823137CV1466231single nucleotide variantNM_030662.4(MAP2K2):c.940C>A (p.Pro314Thr)RASopathy [RCV001879409]uncertain significance1940973234097323Human1name
151873796CV1470269single nucleotide variantNM_030662.4(MAP2K2):c.521G>C (p.Ser174Thr)RASopathy [RCV001885605]uncertain significance1941023834102383Human1name
151713949CV1476882single nucleotide variantNM_030662.4(MAP2K2):c.554G>A (p.Arg185Gln)RASopathy [RCV001908582]|not provided [RCV004719191]uncertain significance1941012554101255Human1name
151834141CV1489025single nucleotide variantNM_030662.4(MAP2K2):c.527C>T (p.Ala176Val)Cardiovascular phenotype [RCV003299065]|RASopathy [RCV001902105]uncertain significance1941023774102377Human1name
151766087CV1496085single nucleotide variantNM_030662.4(MAP2K2):c.558G>T (p.Glu186Asp)RASopathy [RCV001873987]uncertain significance1941012514101251Human1name
151734930CV1502460single nucleotide variantNM_030662.4(MAP2K2):c.370G>A (p.Glu124Lys)RASopathy [RCV001911281]uncertain significance1941105894110589Human1name
151759279CV1503693single nucleotide variantNM_030662.4(MAP2K2):c.775G>C (p.Glu259Gln)RASopathy [RCV002007666]uncertain significance1940993454099345Human1name
151773663CV1504828single nucleotide variantNM_030662.4(MAP2K2):c.611C>G (p.Ser204Cys)RASopathy [RCV002009087]uncertain significance1941011134101113Human1name
151888652CV1512934single nucleotide variantNM_030662.4(MAP2K2):c.842G>C (p.Arg281Pro)RASopathy [RCV001888011]uncertain significance1940992784099278Human1name
152037316CV1669099single nucleotide variantNM_030662.4(MAP2K2):c.538G>T (p.Gly180Cys)RASopathy [RCV003655347]|not provided [RCV002224151]uncertain significance1941012714101271Human1name
152037875CV1669185single nucleotide variantNM_030662.4(MAP2K2):c.991C>T (p.Pro331Ser)not provided [RCV002224237]uncertain significance1940954434095443Humanname
152038719CV1669317single nucleotide variantNM_030662.4(MAP2K2):c.449T>C (p.Met150Thr)RASopathy [RCV003774654]|not provided [RCV002224369]|not specified [RCV003403731]uncertain significance1941105104110510Human1name
9689097CV176028single nucleotide variantNM_030662.4(MAP2K2):c.806C>G (p.Pro269Arg)Cardiofaciocutaneous syndrome 4 [RCV005025235]|Cardiovascular phenotype [RCV003162628]|MAP2K2-related disorder [RCV003416007]|RASopathy [RCV001172272]|not provided [RCV000681198]|not specified [RCV000154524]likely benign|uncertain significance1940993144099314Human2name , trait , alternate_id
9689088CV176031single nucleotide variantNM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys)Cardio-facio-cutaneous syndrome [RCV000208747]|Noonan syndrome 1 [RCV003453160]|Noonan syndrome [RCV000844676]|RASopathy [RCV000154507]|not provided [RCV000412815]pathogenic|likely pathogenic|not provided1941105584110558Human4name
9689061CV176169single nucleotide variantNM_030662.4(MAP2K2):c.985C>T (p.Pro329Ser)Cardiovascular phenotype [RCV004019851]|RASopathy [RCV005089745]|not specified [RCV000154480]uncertain significance1940954494095449Human1name
9689079CV176170single nucleotide variantNM_030662.4(MAP2K2):c.658A>G (p.Ile220Val)not specified [RCV000154498]likely benign1941010664101066Humanname
9691001CV176171single nucleotide variantNM_030662.4(MAP2K2):c.578G>A (p.Arg193Gln)Cardiovascular phenotype [RCV003162645]|MAP2K2-related disorder [RCV003407584]|RASopathy [RCV000686315]|not specified [RCV000156700]uncertain significance1941012314101231Human2name , trait , alternate_id
155745678CV1771583single nucleotide variantNM_030662.4(MAP2K2):c.547T>C (p.Tyr183His)RASopathy [RCV002303364]uncertain significance1941012624101262Human1name
155750070CV1772944single nucleotide variantNM_030662.4(MAP2K2):c.419A>C (p.Asp140Ala)RASopathy [RCV002305319]uncertain significance1941105404110540Human1name
155677963CV1776144single nucleotide variantNM_030662.4(MAP2K2):c.872C>G (p.Pro291Arg)Cardiovascular phenotype [RCV002373088]|RASopathy [RCV002299965]uncertain significance1940992484099248Human1name
155740846CV1777050single nucleotide variantNM_030662.4(MAP2K2):c.976G>T (p.Val326Leu)RASopathy [RCV002302373]uncertain significance1940972874097287Human1name
155671978CV1796617single nucleotide variantNM_030662.4(MAP2K2):c.377A>G (p.Asn126Ser)Cardiovascular phenotype [RCV002351129]uncertain significance1941105824110582Humanname
155686866CV1796722single nucleotide variantNM_030662.4(MAP2K2):c.391G>T (p.Val131Leu)Cardiofaciocutaneous syndrome 4 [RCV005019179]|Cardiovascular phenotype [RCV002373177]|RASopathy [RCV003655362]uncertain significance1941105684110568Human2name
155741115CV1797552single nucleotide variantNM_030662.4(MAP2K2):c.415A>G (p.Ser139Gly)Cardiovascular phenotype [RCV002333297]uncertain significance1941105444110544Humanname
9832805CV179821single nucleotide variantNM_030662.4(MAP2K2):c.971A>G (p.Tyr324Cys)Cardiofaciocutaneous syndrome 4 [RCV003325190]|RASopathy [RCV001850203]|not provided [RCV000158032]uncertain significance1940972924097292Human2name
9832796CV179822single nucleotide variantNM_030662.4(MAP2K2):c.913G>A (p.Val305Ile)Cardiofaciocutaneous syndrome 4 [RCV005025240]|RASopathy [RCV001296102]|not provided [RCV000158017]likely benign|uncertain significance1940992074099207Human2name
9832800CV179823single nucleotide variantNM_030662.4(MAP2K2):c.806C>T (p.Pro269Leu)Cardiofaciocutaneous syndrome 4 [RCV005394542]|RASopathy [RCV001857558]|not provided [RCV000588108]uncertain significance1940993144099314Human2name
9832817CV179824single nucleotide variantNM_030662.4(MAP2K2):c.787G>A (p.Gly263Arg)RASopathy [RCV005055639]|not provided [RCV000158047]|not specified [RCV002247552]likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance1940993334099333Human1name
9832798CV179825single nucleotide variantNM_030662.4(MAP2K2):c.535C>T (p.Arg179Trp)Cardiofaciocutaneous syndrome 4 [RCV002484967]|MAP2K2-related disorder [RCV003895069]|RASopathy [RCV000519027]|not provided [RCV000158023]likely benign|conflicting interpretations of pathogenicity|uncertain significance1941012744101274Human2name , trait , alternate_id
9832816CV179826single nucleotide variantNM_030662.4(MAP2K2):c.313C>G (p.Leu105Val)not provided [RCV000158046]uncertain significance1941106464110646Humanname
155737378CV1801909single nucleotide variantNM_030662.4(MAP2K2):c.484G>A (p.Ala162Thr)Cardiovascular phenotype [RCV002330803]uncertain significance1941024204102420Humanname
155708647CV1819306single nucleotide variantNM_030662.4(MAP2K2):c.712C>T (p.Arg238Trp)Cardiofaciocutaneous syndrome 4 [RCV003741308]|Cardiovascular phenotype [RCV002378338]uncertain significance1940994084099408Human1name
155700136CV1821016single nucleotide variantNM_030662.4(MAP2K2):c.899C>A (p.Pro300His)Cardiovascular phenotype [RCV002376303]|RASopathy [RCV003103548]uncertain significance1940992214099221Human1name
155804236CV1866669single nucleotide variantNM_030662.4(MAP2K2):c.520A>G (p.Ser174Gly)not provided [RCV002481217]uncertain significance1941023844102384Humanname
155944032CV1878954single nucleotide variantNM_030662.4(MAP2K2):c.758T>C (p.Met253Thr)Cardiofaciocutaneous syndrome 4 [RCV005019599]|RASopathy [RCV003073730]uncertain significance1940993624099362Human2name
156271009CV1915308single nucleotide variantNM_030662.4(MAP2K2):c.403G>A (p.Gly135Arg)RASopathy [RCV002628094]|not provided [RCV003329461]uncertain significance1941105564110556Human1name
156302760CV1916199single nucleotide variantNM_030662.4(MAP2K2):c.871C>G (p.Pro291Ala)Cardiofaciocutaneous syndrome 4 [RCV005233094]|RASopathy [RCV002599253]uncertain significance1940992494099249Human2name
156295904CV1924113single nucleotide variantNM_030662.4(MAP2K2):c.904G>A (p.Gly302Arg)RASopathy [RCV002629014]uncertain significance1940992164099216Human1name
155944751CV1935549single nucleotide variantNM_030662.4(MAP2K2):c.674A>C (p.Asn225Thr)Cardiovascular phenotype [RCV003308138]|not provided [RCV002511296]uncertain significance1941010504101050Humanname
156438945CV1943867single nucleotide variantNM_030662.4(MAP2K2):c.901C>G (p.Pro301Ala)RASopathy [RCV003108895]uncertain significance1940992194099219Human1name
156257831CV2000174single nucleotide variantNM_030662.4(MAP2K2):c.350G>A (p.Arg117His)RASopathy [RCV002627662]uncertain significance1941106094110609Human1name
156297485CV2017136single nucleotide variantNM_030662.4(MAP2K2):c.334C>T (p.Arg112Trp)RASopathy [RCV002715909]likely pathogenic1941106254110625Human1name
156275449CV2023472single nucleotide variantNM_030662.4(MAP2K2):c.685G>A (p.Gly229Ser)RASopathy [RCV002746784]uncertain significance1941010394101039Human1name
155951314CV2026240single nucleotide variantNM_030662.4(MAP2K2):c.518T>C (p.Val173Ala)RASopathy [RCV002730695]uncertain significance1941023864102386Human1name
156024990CV2037187single nucleotide variantNM_030662.4(MAP2K2):c.925G>A (p.Gly309Arg)Cardiofaciocutaneous syndrome 4 [RCV005019401]|RASopathy [RCV002795770]likely benign|uncertain significance1940973384097338Human2name
156321293CV2057107single nucleotide variantNM_030662.4(MAP2K2):c.745G>T (p.Asp249Tyr)RASopathy [RCV002810089]uncertain significance1940993754099375Human1name
156014916CV2061552single nucleotide variantNM_030662.4(MAP2K2):c.565C>G (p.Gln189Glu)RASopathy [RCV002820324]uncertain significance1941012444101244Human1name
156171108CV2075566single nucleotide variantNM_030662.4(MAP2K2):c.602T>C (p.Leu201Pro)RASopathy [RCV002851532]uncertain significance1941011224101122Human1name
155963213CV2140829single nucleotide variantNM_030662.4(MAP2K2):c.551T>C (p.Leu184Pro)RASopathy [RCV003015574]uncertain significance1941012584101258Human1name
156024285CV2175079single nucleotide variantNM_030662.4(MAP2K2):c.767C>G (p.Ser256Cys)RASopathy [RCV003035885]uncertain significance1940993534099353Human1name
156138740CV2186737single nucleotide variantNM_030662.4(MAP2K2):c.454G>T (p.Gly152Cys)RASopathy [RCV003056100]uncertain significance1941024504102450Human1name
156261772CV2191062single nucleotide variantNM_030662.4(MAP2K2):c.542T>C (p.Leu181Ser)Cardiovascular phenotype [RCV004070093]|RASopathy [RCV003044143]uncertain significance1941012674101267Human1name
156128571CV2220050single nucleotide variantNM_030662.4(MAP2K2):c.727C>A (p.His243Asn)Cardiovascular phenotype [RCV004093927]uncertain significance1940993934099393Humanname
156124150CV2227314single nucleotide variantNM_030662.4(MAP2K2):c.897G>C (p.Arg299Ser)Cardiovascular phenotype [RCV004091861]uncertain significance1940992234099223Humanname
11091886CV231026single nucleotide variantNM_030662.4(MAP2K2):c.326C>T (p.Pro109Leu)Cardiofaciocutaneous syndrome 4 [RCV005016572]|Noonan syndrome 1 [RCV003454599]|RASopathy [RCV002517564]|not provided [RCV000680337]|not specified [RCV000217864]uncertain significance1941106334110633Human3name
8572472CV23313single nucleotide variantNM_030662.4(MAP2K2):c.400T>C (p.Tyr134His)Cardio-facio-cutaneous syndrome [RCV000008763]|Cardiofaciocutaneous syndrome 4 [RCV000043675]|MAP2K2-related disorder [RCV003390660]|Noonan syndrome 1 [RCV003450621]|Noonan syndrome and Noonan-related syndrome [RCV001813182]|RASopathy [RCV000521479]|not providedpathogenic|likely pathogenic1941105594110559Human5name , trait , alternate_id
8560419CV23314single nucleotide variantNM_030662.4(MAP2K2):c.383C>A (p.Pro128Gln)Cardio-facio-cutaneous syndrome [RCV000208770]|Cardiofaciocutaneous syndrome 4 [RCV000008764]|RASopathy [RCV004760323]|not provided [RCV000158021]pathogenic|not provided1941105764110576Human3name
243052992CV2416248single nucleotide variantNM_030662.4(MAP2K2):c.317A>C (p.Glu106Ala)not provided [RCV003149309]uncertain significance1941106424110642Humanname
329385302CV2423100single nucleotide variantNM_030662.4(MAP2K2):c.743C>G (p.Ser248Trp)Cardiovascular phenotype [RCV003177073]uncertain significance1940993774099377Humanname
329351057CV2477887single nucleotide variantNM_030662.4(MAP2K2):c.360G>T (p.Gln120His)not provided [RCV003224000]uncertain significance1941105994110599Humanname
329847148CV2534307single nucleotide variantNM_030662.4(MAP2K2):c.455G>A (p.Gly152Asp)not provided [RCV003228516]uncertain significance1941024494102449Humanname
11641744CV264952single nucleotide variantNM_030662.4(MAP2K2):c.937C>T (p.Arg313Trp)Cardiofaciocutaneous syndrome 4 [RCV000656742]|Cardiovascular phenotype [RCV002374449]|RASopathy [RCV001859537]|not provided [RCV000360631]uncertain significance1940973264097326Human2name
11639162CV265085single nucleotide variantNM_030662.4(MAP2K2):c.536G>A (p.Arg179Gln)Cardiofaciocutaneous syndrome 4 [RCV005016664]|Cardiovascular phenotype [RCV004021071]|MAP2K2-related disorder [RCV003417878]|RASopathy [RCV001348032]|not provided [RCV000315212]likely benign|uncertain significance1941012734101273Human2name , trait , alternate_id
329848154CV2667773single nucleotide variantNM_030662.4(MAP2K2):c.653A>T (p.Gln218Leu)RASopathy [RCV003539480]|not provided [RCV003229340]uncertain significance1941010714101071Human1name
11639022CV268100single nucleotide variantNM_030662.4(MAP2K2):c.904G>C (p.Gly302Arg)not provided [RCV000313977]uncertain significance1940992164099216Humanname
11638789CV269358single nucleotide variantNM_030662.4(MAP2K2):c.890G>A (p.Arg297Gln)Cardiofaciocutaneous syndrome 4 [RCV000764204]|RASopathy [RCV000690698]|not provided [RCV000680326]conflicting interpretations of pathogenicity|uncertain significance1940992304099230Human2name
401732902CV2736779single nucleotide variantNM_030662.4(MAP2K2):c.757A>T (p.Met253Leu)not provided [RCV003313541]uncertain significance1940993634099363Humanname
401720214CV2737197single nucleotide variantNM_030662.4(MAP2K2):c.829G>A (p.Ala277Thr)not provided [RCV003314136]uncertain significance1940992914099291Humanname
401864131CV2773439single nucleotide variantNM_030662.4(MAP2K2):c.932A>G (p.Asp311Gly)Cardiovascular phenotype [RCV004354076]uncertain significance1940973314097331Humanname
401920215CV2796536single nucleotide variantNM_030662.4(MAP2K2):c.356T>C (p.Leu119Pro)MAP2K2-related disorder [RCV003402572]uncertain significance1941106034110603Humanname , trait , alternate_id
405158906CV2876640single nucleotide variantNM_030662.4(MAP2K2):c.727C>G (p.His243Asp)RASopathy [RCV003539695]uncertain significance1940993934099393Human1name
405161863CV2899716single nucleotide variantNM_030662.4(MAP2K2):c.386A>C (p.Tyr129Ser)RASopathy [RCV003540185]uncertain significance1941105734110573Human1name
405163374CV2913863single nucleotide variantNM_030662.4(MAP2K2):c.924C>G (p.His308Gln)RASopathy [RCV003540306]uncertain significance1940973394097339Human1name
405164356CV2928281single nucleotide variantNM_030662.4(MAP2K2):c.386A>G (p.Tyr129Cys)RASopathy [RCV003540386]uncertain significance1941105734110573Human1name
405164485CV2931439single nucleotide variantNM_030662.4(MAP2K2):c.548A>G (p.Tyr183Cys)RASopathy [RCV003540397]uncertain significance1941012614101261Human1name
405164695CV2931980single nucleotide variantNM_030662.4(MAP2K2):c.655C>G (p.Leu219Val)RASopathy [RCV003540415]uncertain significance1941010694101069Human1name
405164890CV2932638single nucleotide variantNM_030662.4(MAP2K2):c.713G>A (p.Arg238Gln)RASopathy [RCV003540430]uncertain significance1940994074099407Human1name
405054451CV2936646single nucleotide variantNM_030662.4(MAP2K2):c.806C>A (p.Pro269Gln)RASopathy [RCV003655446]uncertain significance1940993144099314Human1name
405059918CV2971606single nucleotide variantNM_030662.4(MAP2K2):c.956T>C (p.Phe319Ser)RASopathy [RCV003655662]uncertain significance1940973074097307Human1name
405058731CV2978947single nucleotide variantNM_030662.4(MAP2K2):c.694T>A (p.Ser232Thr)RASopathy [RCV003655787]uncertain significance1941010304101030Human1name
405059488CV2994597single nucleotide variantNM_030662.4(MAP2K2):c.886C>T (p.Pro296Ser)RASopathy [RCV003655843]uncertain significance1940992344099234Human1name
405061585CV3009670single nucleotide variantNM_030662.4(MAP2K2):c.674A>T (p.Asn225Ile)RASopathy [RCV003655986]uncertain significance1941010504101050Human1name
405049548CV3046085single nucleotide variantNM_030662.4(MAP2K2):c.532C>G (p.Leu178Val)RASopathy [RCV003654648]uncertain significance1941012774101277Human1name
405048788CV3050079single nucleotide variantNM_030662.4(MAP2K2):c.854A>T (p.Asp285Val)RASopathy [RCV003654589]uncertain significance1940992664099266Human1name
405049726CV3056331single nucleotide variantNM_030662.4(MAP2K2):c.626A>G (p.Lys209Arg)RASopathy [RCV003654662]uncertain significance1941010984101098Human1name
405050463CV3060587single nucleotide variantNM_030662.4(MAP2K2):c.791G>A (p.Arg264Lys)RASopathy [RCV003654696]uncertain significance1940993294099329Human1name
405050622CV3067824single nucleotide variantNM_030662.4(MAP2K2):c.874C>T (p.His292Tyr)Cardiofaciocutaneous syndrome 4 [RCV005030239]|RASopathy [RCV003654708]uncertain significance1940992464099246Human2name
405052443CV3076231single nucleotide variantNM_030662.4(MAP2K2):c.305T>C (p.Leu102Pro)RASopathy [RCV003654850]uncertain significance1941106544110654Human1name
405057065CV3081379single nucleotide variantNM_030662.4(MAP2K2):c.650G>C (p.Gly217Ala)Cardiofaciocutaneous syndrome 4 [RCV003741142]uncertain significance1941010744101074Human1name
405007998CV3117524single nucleotide variantNM_030662.4(MAP2K2):c.946A>G (p.Met316Val)Cardiofaciocutaneous syndrome 4 [RCV005030288]|RASopathy [RCV003828579]uncertain significance1940973174097317Human2name
405214330CV3143115single nucleotide variantNM_030662.4(MAP2K2):c.572T>C (p.Met191Thr)RASopathy [RCV003846278]uncertain significance1941012374101237Human1name
405216781CV3143436single nucleotide variantNM_030662.4(MAP2K2):c.539G>A (p.Gly180Asp)RASopathy [RCV003846600]uncertain significance1941012704101270Human1name
405188072CV3156583single nucleotide variantNM_030662.4(MAP2K2):c.739C>T (p.Gln247Ter)RASopathy [RCV003859461]uncertain significance1940993814099381Human1name
405254830CV3175559single nucleotide variantNM_030662.4(MAP2K2):c.917G>T (p.Ser306Ile)RASopathy [RCV003871826]uncertain significance1940992034099203Human1name
405291121CV3222078single nucleotide variantNM_030662.4(MAP2K2):c.404G>T (p.Gly135Val)Cardiofaciocutaneous syndrome 4 [RCV003984897]|RASopathy [RCV005103149]likely pathogenic|uncertain significance1941105554110555Human2name
405683291CV3387822single nucleotide variantNM_030662.4(MAP2K2):c.346A>G (p.Ile116Val)Cardiovascular phenotype [RCV004517797]|RASopathy [RCV005100634]uncertain significance1941106134110613Human1name
405683305CV3387826single nucleotide variantNM_030662.4(MAP2K2):c.794A>G (p.Tyr265Cys)Cardiofaciocutaneous syndrome 4 [RCV005023557]|Cardiovascular phenotype [RCV004517801]uncertain significance1940993264099326Human1name
407493703CV3446442single nucleotide variantNM_030662.4(MAP2K2):c.857G>A (p.Gly286Glu)Cardiovascular phenotype [RCV004642807]|RASopathy [RCV005102280]uncertain significance1940992634099263Human1name
408380621CV3523608single nucleotide variantNM_030662.4(MAP2K2):c.368A>C (p.His123Pro)not provided [RCV004766006]likely pathogenic1941105914110591Humanname
408388940CV3529152single nucleotide variantNM_030662.4(MAP2K2):c.734C>T (p.Ser245Leu)not provided [RCV004773974]uncertain significance1940993864099386Humanname
12740807CV360426single nucleotide variantNM_030662.4(MAP2K2):c.834C>G (p.Ile278Met)RASopathy [RCV000458371]|not specified [RCV000413176]uncertain significance1940992864099286Human1name
12740994CV360428single nucleotide variantNM_030662.4(MAP2K2):c.541T>A (p.Leu181Met)not specified [RCV000413749]uncertain significance1941012684101268Humanname
12740664CV360554single nucleotide variantNM_030662.4(MAP2K2):c.826G>C (p.Glu276Gln)Cardiovascular phenotype [RCV005372303]|RASopathy [RCV001861423]|not specified [RCV000412732]uncertain significance1940992944099294Human1name
12839847CV363055single nucleotide variantNM_030662.4(MAP2K2):c.376A>G (p.Asn126Asp)Cardio-facio-cutaneous syndrome [RCV000824947]|Cardiofaciocutaneous syndrome 4 [RCV000995803]|RASopathy [RCV001851015]pathogenic|likely pathogenic1941105834110583Human3name
12844722CV363056single nucleotide variantNM_030662.4(MAP2K2):c.373T>A (p.Cys125Ser)Melanoma [RCV000438500]likely pathogenic1941105864110586Human1name
597729914CV3699985single nucleotide variantNM_030662.4(MAP2K2):c.836T>G (p.Phe279Cys)Cardiovascular phenotype [RCV004995635]uncertain significance1940992844099284Humanname
597729927CV3699990single nucleotide variantNM_030662.4(MAP2K2):c.646A>G (p.Ser216Gly)Cardiovascular phenotype [RCV004995639]uncertain significance1941010784101078Humanname
597750969CV3709751single nucleotide variantNM_030662.4(MAP2K2):c.695C>T (p.Ser232Phe)Cardiofaciocutaneous syndrome 4 [RCV005015759]uncertain significance1941010294101029Human1name
597662509CV3709752single nucleotide variantNM_030662.4(MAP2K2):c.674A>G (p.Asn225Ser)Cardiofaciocutaneous syndrome 4 [RCV005028646]|RASopathy [RCV005063228]uncertain significance1941010504101050Human2name
597662515CV3709753single nucleotide variantNM_030662.4(MAP2K2):c.590C>T (p.Pro197Leu)Cardiofaciocutaneous syndrome 4 [RCV005028647]|RASopathy [RCV005112716]uncertain significance1941011344101134Human2name
597662522CV3709754single nucleotide variantNM_030662.4(MAP2K2):c.500A>G (p.Glu167Gly)Cardiofaciocutaneous syndrome 4 [RCV005028648]uncertain significance1941024044102404Human1name
597662529CV3709755single nucleotide variantNM_030662.4(MAP2K2):c.491G>A (p.Arg164Lys)Cardiofaciocutaneous syndrome 4 [RCV005028649]uncertain significance1941024134102413Human1name
597750974CV3709756single nucleotide variantNM_030662.4(MAP2K2):c.464T>C (p.Leu155Pro)Cardiofaciocutaneous syndrome 4 [RCV005015760]uncertain significance1941024404102440Human1name
597653792CV3731356single nucleotide variantNM_030662.4(MAP2K2):c.792G>T (p.Arg264Ser)not provided [RCV005001536]uncertain significance1940993284099328Humanname
597833716CV3735068single nucleotide variantNM_030662.4(MAP2K2):c.329C>T (p.Ala110Val)not provided [RCV005054801]uncertain significance1941106304110630Humanname
597834362CV3735840single nucleotide variantNM_030662.4(MAP2K2):c.833T>C (p.Ile278Thr)not provided [RCV005063703]uncertain significance1940992874099287Humanname
597956160CV3754548single nucleotide variantNM_030662.4(MAP2K2):c.413A>G (p.Tyr138Cys)RASopathy [RCV005080398]uncertain significance1941105464110546Human1name
597956375CV3754620single nucleotide variantNM_030662.4(MAP2K2):c.488A>G (p.Lys163Arg)RASopathy [RCV005080470]uncertain significance1941024164102416Human1name
597836954CV3761416single nucleotide variantNM_030662.4(MAP2K2):c.823C>G (p.Leu275Val)RASopathy [RCV005085787]uncertain significance1940992974099297Human1name
12847667CV376562single nucleotide variantNM_030662.4(MAP2K2):c.475C>G (p.Leu159Val)not provided [RCV000443892]uncertain significance1941024294102429Humanname
597905364CV3772909single nucleotide variantNM_030662.4(MAP2K2):c.624C>G (p.Ile208Met)RASopathy [RCV005112974]uncertain significance1941011004101100Human1name
597885812CV3774379single nucleotide variantNM_030662.4(MAP2K2):c.926G>A (p.Gly309Glu)RASopathy [RCV005109933]uncertain significance1940973374097337Human1name
597885818CV3774380single nucleotide variantNM_030662.4(MAP2K2):c.797C>G (p.Pro266Arg)RASopathy [RCV005109934]uncertain significance1940993234099323Human1name
597885825CV3774381single nucleotide variantNM_030662.4(MAP2K2):c.664T>C (p.Ser222Pro)RASopathy [RCV005109935]uncertain significance1941010604101060Human1name
597885831CV3774382single nucleotide variantNM_030662.4(MAP2K2):c.649G>C (p.Gly217Arg)RASopathy [RCV005109936]uncertain significance1941010754101075Human1name
597885836CV3774383single nucleotide variantNM_030662.4(MAP2K2):c.595A>C (p.Asn199His)RASopathy [RCV005109937]uncertain significance1941011294101129Human1name
597885843CV3774384single nucleotide variantNM_030662.4(MAP2K2):c.511G>A (p.Gly171Arg)RASopathy [RCV005109938]uncertain significance1941023934102393Human1name
597885849CV3774385single nucleotide variantNM_030662.4(MAP2K2):c.497C>T (p.Pro166Leu)RASopathy [RCV005109939]uncertain significance1941024074102407Human1name
597885855CV3774386single nucleotide variantNM_030662.4(MAP2K2):c.447C>G (p.His149Gln)RASopathy [RCV005109940]uncertain significance1941105124110512Human1name
597899188CV3774387single nucleotide variantNM_030662.4(MAP2K2):c.390C>G (p.Ile130Met)RASopathy [RCV005111923]uncertain significance1941105694110569Human1name
597954749CV3796069single nucleotide variantNM_030662.4(MAP2K2):c.338A>G (p.Asn113Ser)RASopathy [RCV005136886]uncertain significance1941106214110621Human1name
597857650CV3822278single nucleotide variantNM_030662.4(MAP2K2):c.853G>C (p.Asp285His)RASopathy [RCV005174576]uncertain significance1940992674099267Human1name
597844349CV3827447single nucleotide variantNM_030662.4(MAP2K2):c.539G>T (p.Gly180Val)RASopathy [RCV005172718]uncertain significance1941012704101270Human1name
597883196CV3834144single nucleotide variantNM_030662.4(MAP2K2):c.496C>T (p.Pro166Ser)RASopathy [RCV005178463]uncertain significance1941024084102408Human1name
597891263CV3856555single nucleotide variantNM_030662.4(MAP2K2):c.448A>G (p.Met150Val)RASopathy [RCV005200620]uncertain significance1941105114110511Human1name
597935434CV3863678single nucleotide variantNM_030662.4(MAP2K2):c.700A>G (p.Met234Val)not provided [RCV005207491]uncertain significance1941010244101024Humanname
8568157CV39126single nucleotide variantNM_030662.4(MAP2K2):c.395G>A (p.Gly132Asp)Cardiofaciocutaneous syndrome 4 [RCV000023088]|Cardiovascular phenotype [RCV005372225]|RASopathy [RCV000149835]|not provided [RCV000413893]pathogenic|likely pathogenic1941105644110564Human2name
598196846CV3988649single nucleotide variantNM_030662.4(MAP2K2):c.560A>G (p.Lys187Arg)Cardiovascular phenotype [RCV005375335]uncertain significance1941012494101249Humanname
12881208CV403729single nucleotide variantNM_030662.4(MAP2K2):c.325C>G (p.Pro109Ala)Noonan syndrome [RCV000824946]|RASopathy [RCV000457414]|not provided [RCV005414499]likely benign|uncertain significance1941106344110634Human2name
12901367CV410613single nucleotide variantNM_030662.4(MAP2K2):c.952A>G (p.Ile318Val)Cardiovascular phenotype [RCV003278838]|RASopathy [RCV003539906]|not provided [RCV000484509]likely benign|uncertain significance1940973114097311Human1name
12900451CV410616single nucleotide variantNM_030662.4(MAP2K2):c.814G>A (p.Ala272Thr)Cardiofaciocutaneous syndrome 4 [RCV003129871]|Cardiovascular phenotype [RCV002420244]|RASopathy [RCV002526970]|not provided [RCV000680366]|not specified [RCV000482431]likely benign|uncertain significance1940993064099306Human2name
12901148CV410617single nucleotide variantNM_030662.4(MAP2K2):c.454G>A (p.Gly152Ser)RASopathy [RCV005056058]|not provided [RCV000484028]uncertain significance1941024504102450Human1name
12905545CV413490single nucleotide variantNM_030662.4(MAP2K2):c.682G>A (p.Val228Met)RASopathy [RCV003766733]|not provided [RCV000487640]uncertain significance1941010424101042Human1name
13211886CV426315single nucleotide variantNM_030662.4(MAP2K2):c.331A>T (p.Ile111Phe)Cardiofaciocutaneous syndrome 4 [RCV005018837]|RASopathy [RCV002527158]|not provided [RCV000498041]uncertain significance1941106284110628Human2name
13504513CV442539single nucleotide variantNM_030662.4(MAP2K2):c.847G>T (p.Val283Leu)Cardiofaciocutaneous syndrome 4 [RCV005018888]|RASopathy [RCV000520355]likely benign|uncertain significance1940992734099273Human2name
13520572CV487813single nucleotide variantNM_030662.4(MAP2K2):c.627G>C (p.Lys209Asn)RASopathy [RCV001860145]|not provided [RCV000587985]uncertain significance1941010974101097Human1name
13519781CV488053single nucleotide variantNM_030662.4(MAP2K2):c.847G>A (p.Val283Met)Cardiofaciocutaneous syndrome 4 [RCV005027696]|RASopathy [RCV001295722]|not specified [RCV003994033]likely benign|uncertain significance1940992734099273Human2name
13536049CV49260single nucleotide variantNM_030662.4(MAP2K2):c.320T>A (p.Ile107Asn)RASopathy [RCV001059467]|not provided [RCV004799753]|not specified [RCV000608440]uncertain significance1941106394110639Human1name
156329415CV49261single nucleotide variantNM_030662.4(MAP2K2):c.335G>A (p.Arg112Gln)Cardiofaciocutaneous syndrome 4 [RCV005019475]|RASopathy [RCV002938281]likely pathogenic|uncertain significance1941106244110624Human2name
9688987CV49262single nucleotide variantNM_030662.4(MAP2K2):c.383C>G (p.Pro128Arg)not specified [RCV000154387]uncertain significance1941105764110576Humanname
150431138CV49271single nucleotide variantNM_030662.4(MAP2K2):c.485C>T (p.Ala162Val)RASopathy [RCV001866196]|not provided [RCV001580898]uncertain significance1941024194102419Human1name
155742448CV49273single nucleotide variantNM_030662.4(MAP2K2):c.526G>A (p.Ala176Thr)Cardiovascular phenotype [RCV002344386]|RASopathy [RCV003096675]uncertain significance1941023784102378Human1name
156028275CV49277single nucleotide variantNM_030662.4(MAP2K2):c.545C>T (p.Ala182Val)RASopathy [RCV002909945]uncertain significance1941012644101264Human1name
26917375CV49282single nucleotide variantNM_030662.4(MAP2K2):c.604G>A (p.Val202Met)Cardiofaciocutaneous syndrome 4 [RCV003129759]|Cardiovascular phenotype [RCV004018725]|RASopathy [RCV001042609]|not specified [RCV001582507]uncertain significance1941011204101120Human2name
9689112CV49283single nucleotide variantNM_030662.4(MAP2K2):c.619G>A (p.Glu207Lys)Cardio-facio-cutaneous syndrome [RCV000524055]|Noonan syndrome [RCV000844675]|RASopathy [RCV000158024]|not provided [RCV000254662]pathogenic|likely pathogenic1941011054101105Human3name
155713905CV49284single nucleotide variantNM_030662.4(MAP2K2):c.649G>A (p.Gly217Ser)Cardiovascular phenotype [RCV002362026]|RASopathy [RCV005096950]uncertain significance1941010754101075Human1name
156416388CV49287single nucleotide variantNM_030662.4(MAP2K2):c.691C>T (p.Arg231Cys)RASopathy [RCV002610151]uncertain significance1941010334101033Human1name
9832799CV49288single nucleotide variantNM_030662.4(MAP2K2):c.692G>T (p.Arg231Leu)Cardiofaciocutaneous syndrome 4 [RCV001849290]|Noonan syndrome and Noonan-related syndrome [RCV000788004]|Noonan syndrome with multiple lentigines [RCV000824948]|RASopathy [RCV000466246]|not provided [RCV000158025]likely pathogenic|uncertain significance1941010324101032Human3name
9832801CV49294single nucleotide variantNM_030662.4(MAP2K2):c.818A>G (p.Lys273Arg)Cardiofaciocutaneous syndrome 4 [RCV000990136]|MAP2K2-related disorder [RCV003952390]|RASopathy [RCV000522446]|not provided [RCV000158027]|not specified [RCV000781517]likely pathogenic|likely benign|uncertain significance1940993024099302Human2name , trait , alternate_id
8609110CV49296single nucleotide variantNM_030662.4(MAP2K2):c.844C>T (p.Pro282Ser)Cardiovascular phenotype [RCV003343604]|MAP2K2-related disorder [RCV003944871]|Noonan syndrome [RCV000824950]|RASopathy [RCV000522371]|not provided [RCV000680293]|not specified [RCV000039495]benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance1940992764099276Human3name , trait , alternate_id
9832802CV49298single nucleotide variantNM_030662.4(MAP2K2):c.853G>A (p.Asp285Asn)Noonan syndrome [RCV001261064]|RASopathy [RCV001480813]|not provided [RCV000680294]|not specified [RCV000158029]likely benign|conflicting interpretations of pathogenicity|uncertain significance1940992674099267Human2name
9832818CV49299single nucleotide variantNM_030662.4(MAP2K2):c.856G>A (p.Gly286Arg)Cardiofaciocutaneous syndrome 4 [RCV005394191]|Cardiovascular phenotype [RCV004018726]|RASopathy [RCV000654943]|not provided [RCV000158048]conflicting interpretations of pathogenicity|uncertain significance1940992644099264Human2name
9832803CV49300single nucleotide variantNM_030662.4(MAP2K2):c.884C>T (p.Ser295Leu)Cardiofaciocutaneous syndrome 4 [RCV005016318]|Cardiovascular phenotype [RCV005372226]|RASopathy [RCV001852682]|not provided [RCV000158030]likely benign|uncertain significance1940992364099236Human2name
13520727CV49301single nucleotide variantNM_030662.4(MAP2K2):c.889C>T (p.Arg297Trp)RASopathy [RCV001243507]|not provided [RCV000588230]likely benign|uncertain significance1940992314099231Human1name
9689073CV49302single nucleotide variantNM_030662.4(MAP2K2):c.893C>T (p.Pro298Leu)Cardiovascular phenotype [RCV005364906]|Hypertrophic cardiomyopathy [RCV000852749]|Noonan syndrome and Noonan-related syndrome [RCV001813317]|RASopathy [RCV000227476]|not provided [RCV000586661]|not specified [RCV000154492]benign|likely benign1940992274099227Human3name
9832804CV49309single nucleotide variantNM_030662.4(MAP2K2):c.938G>A (p.Arg313Gln)Cardiofaciocutaneous syndrome 4 [RCV002482944]|Cardiovascular phenotype [RCV002371815]|Noonan syndrome [RCV000761056]|Noonan syndrome and Noonan-related syndrome [RCV001813318]|RASopathy [RCV001062526]|not provided [RCV000767154]|not specified [RCV000158031]uncertain significance1940973254097325Human3name
13612232CV514098single nucleotide variantNM_030662.4(MAP2K2):c.514A>G (p.Lys172Glu)MAP2K2-related disorder [RCV003420086]|Migraine [RCV000626968]|RASopathy [RCV002529800]uncertain significance1941023904102390Human17name , trait , alternate_id
13626536CV533045single nucleotide variantNM_030662.4(MAP2K2):c.692G>A (p.Arg231His)Cardiofaciocutaneous syndrome 4 [RCV005019090]|MAP2K2-related disorder [RCV004745538]|Noonan syndrome and Noonan-related syndrome [RCV000788005]|RASopathy [RCV000654976]|not provided [RCV001797120]uncertain significance1941010324101032Human2name , trait , alternate_id
13626503CV533539single nucleotide variantNM_030662.4(MAP2K2):c.865G>A (p.Gly289Arg)Cardiovascular phenotype [RCV003278976]|RASopathy [RCV000654923]uncertain significance1940992554099255Human1name
13626533CV533550single nucleotide variantNM_030662.4(MAP2K2):c.453C>G (p.Asp151Glu)RASopathy [RCV000654973]|not provided [RCV001507910]uncertain significance1941024514102451Human1name
13797764CV553036single nucleotide variantNM_030662.4(MAP2K2):c.605T>G (p.Val202Gly)not provided [RCV000681413]uncertain significance1941011194101119Humanname
8609094CV55399single nucleotide variantNM_030662.4(MAP2K2):c.391G>A (p.Val131Met)RASopathy [RCV003764692]|not specified [RCV000039479]uncertain significance1941105684110568Human1name
8609108CV55407single nucleotide variantNM_030662.4(MAP2K2):c.784G>A (p.Val262Ile)RASopathy [RCV000519690]|not specified [RCV000039493]benign|likely benign|uncertain significance1940993364099336Human1name
13813587CV570803single nucleotide variantNM_030662.4(MAP2K2):c.842G>A (p.Arg281Gln)Cardiofaciocutaneous syndrome 4 [RCV005021062]|RASopathy [RCV000690261]|not provided [RCV001815372]uncertain significance1940992784099278Human2name
13820059CV570804single nucleotide variantNM_030662.4(MAP2K2):c.380C>T (p.Ser127Leu)RASopathy [RCV000694725]|not provided [RCV001756198]uncertain significance1941105794110579Human1name
13817013CV574979single nucleotide variantNM_030662.4(MAP2K2):c.491G>T (p.Arg164Met)Cardiofaciocutaneous syndrome 4 [RCV005021066]|RASopathy [RCV000692716]|not specified [RCV001264512]uncertain significance1941024134102413Human2name
13831746CV582243single nucleotide variantNM_030662.4(MAP2K2):c.707C>T (p.Pro236Leu)Cardiovascular phenotype [RCV003338769]|RASopathy [RCV003540854]|not provided [RCV000722428]uncertain significance1940994134099413Human1name
14396245CV612026single nucleotide variantNM_030662.4(MAP2K2):c.523A>G (p.Ile175Val)Noonan syndrome [RCV000761014]uncertain significance1941023814102381Human1name
14689802CV621637single nucleotide variantNM_030662.4(MAP2K2):c.352G>A (p.Glu118Lys)MAP2K2-related disorder [RCV003396358]|not specified [RCV000780395]uncertain significance1941106074110607Human1name , trait , alternate_id
14702630CV648137single nucleotide variantNM_030662.4(MAP2K2):c.376A>C (p.Asn126His)RASopathy [RCV000807052]uncertain significance1941105834110583Human1name
14745386CV653829single nucleotide variantNM_030662.4(MAP2K2):c.383C>T (p.Pro128Leu)Castleman-Kojima disease [RCV000824698]|MAP2K2-related disorder [RCV003908112]|not provided [RCV003313157]pathogenic1941105764110576Human2name , trait , alternate_id
14702889CV653983single nucleotide variantNM_030662.4(MAP2K2):c.811G>A (p.Asp271Asn)Cardio-facio-cutaneous syndrome [RCV000824949]|Cardiofaciocutaneous syndrome 4 [RCV005029515]|RASopathy [RCV002536037]|not provided [RCV001772146]likely benign|uncertain significance1940993094099309Human3name
26885720CV847719single nucleotide variantNM_030662.4(MAP2K2):c.689C>T (p.Thr230Met)RASopathy [RCV001065619]uncertain significance1941010354101035Human1name
26891650CV847720single nucleotide variantNM_030662.4(MAP2K2):c.682G>C (p.Val228Leu)MAP2K2-related disorder [RCV003983827]|RASopathy [RCV001046546]uncertain significance1941010424101042Human2name , trait , alternate_id
26900220CV847721single nucleotide variantNM_030662.4(MAP2K2):c.643G>T (p.Val215Leu)Cardiovascular phenotype [RCV002365783]|Noonan syndrome [RCV001261063]|RASopathy [RCV001071204]likely benign|uncertain significance1941010814101081Human2name
26908909CV847722single nucleotide variantNM_030662.4(MAP2K2):c.553C>T (p.Arg185Ter)Cardiofaciocutaneous syndrome 4 [RCV005021350]|RASopathy [RCV001038407]uncertain significance1941012564101256Human2name
26913883CV847723single nucleotide variantNM_030662.4(MAP2K2):c.433A>G (p.Ile145Val)Cardiofaciocutaneous syndrome 4 [RCV005021382]|RASopathy [RCV001054554]uncertain significance1941105264110526Human2name
26909260CV847724single nucleotide variantNM_030662.4(MAP2K2):c.335G>T (p.Arg112Leu)Cardiofaciocutaneous syndrome 4 [RCV003741245]|RASopathy [RCV001038482]likely pathogenic1941106244110624Human2name
34891273CV906038single nucleotide variantNM_030662.4(MAP2K2):c.841C>T (p.Arg281Trp)Cardiovascular phenotype [RCV002445415]|RASopathy [RCV001873656]|not specified [RCV001174923]likely benign|uncertain significance1940992794099279Human1name
38460709CV919868single nucleotide variantNM_030662.4(MAP2K2):c.661G>A (p.Asp221Asn)Cardiofaciocutaneous syndrome 4 [RCV001196823]|RASopathy [RCV002560226]uncertain significance1941010634101063Human2name
38478005CV928974single nucleotide variantNM_030662.4(MAP2K2):c.556G>C (p.Glu186Gln)RASopathy [RCV001216409]|not provided [RCV004783920]uncertain significance1941012534101253Human1name
38456974CV950799single nucleotide variantNM_030662.4(MAP2K2):c.986C>T (p.Pro329Leu)Cardiovascular phenotype [RCV002379873]|RASopathy [RCV001228528]uncertain significance1940954484095448Human1name
38456978CV950800single nucleotide variantNM_030662.4(MAP2K2):c.577C>T (p.Arg193Ter)Cardiovascular phenotype [RCV002356972]|RASopathy [RCV001228529]uncertain significance1941012324101232Human1name
38488449CV950801single nucleotide variantNM_030662.4(MAP2K2):c.333C>G (p.Ile111Met)RASopathy [RCV001238021]|not provided [RCV004762014]uncertain significance1941106264110626Human1name
40813858CV969695single nucleotide variantNM_030662.4(MAP2K2):c.640G>A (p.Gly214Arg)MAP2K2-related disorder [RCV003405468]|Noonan syndrome [RCV001261062]|RASopathy [RCV001880002]|not provided [RCV004778033]likely benign|uncertain significance1941010844101084Human3name , trait , alternate_id
126732998CV998616single nucleotide variantNM_030662.4(MAP2K2):c.740A>C (p.Gln247Pro)Cardiovascular phenotype [RCV002384368]|RASopathy [RCV001304190]uncertain significance1940993804099380Human1name
126746331CV1015383single nucleotide variantNM_030662.4(MAP2K2):c.1195G>A (p.Ala399Thr)RASopathy [RCV002546258]|not specified [RCV001328431]uncertain significance1940906064090606Human1name
126733312CV1021895single nucleotide variantNM_030662.4(MAP2K2):c.1042A>G (p.Lys348Glu)Cardiofaciocutaneous syndrome 4 [RCV001334283]|RASopathy [RCV001865804]uncertain significance1940953924095392Human2name
150556279CV1296840single nucleotide variantNM_030662.4(MAP2K2):c.1151G>A (p.Cys384Tyr)RASopathy [RCV003539403]|not provided [RCV001774130]uncertain significance1940906504090650Human1name
151352156CV1325115single nucleotide variantNM_030662.4(MAP2K2):c.1106T>C (p.Ile369Thr)Noonan syndrome and Noonan-related syndrome [RCV001813671]|not provided [RCV004699481]uncertain significance1940906954090695Humanname
151798259CV1337084single nucleotide variantNM_030662.4(MAP2K2):c.1100C>A (p.Thr367Asn)RASopathy [RCV002047740]uncertain significance1940907014090701Human1name
151758875CV1342995single nucleotide variantNM_030662.4(MAP2K2):c.1010T>G (p.Val337Gly)Cardiovascular phenotype [RCV004641897]|RASopathy [RCV002024134]uncertain significance1940954244095424Human1name
151821792CV1355022single nucleotide variantNM_030662.4(MAP2K2):c.1138G>A (p.Ala380Thr)RASopathy [RCV001934214]uncertain significance1940906634090663Human1name
151880195CV1359994single nucleotide variantNM_030662.4(MAP2K2):c.1141G>A (p.Gly381Ser)RASopathy [RCV002036760]|not provided [RCV003481257]uncertain significance1940906604090660Human1name
151793476CV1423086single nucleotide variantNM_030662.4(MAP2K2):c.1019C>G (p.Pro340Arg)RASopathy [RCV001917041]uncertain significance1940954154095415Human1name
151749393CV1430326single nucleotide variantNM_030662.4(MAP2K2):c.1157C>T (p.Thr386Ile)RASopathy [RCV002006704]uncertain significance1940906444090644Human1name
151774619CV1450215single nucleotide variantNM_030662.4(MAP2K2):c.1109A>T (p.Lys370Met)RASopathy [RCV001915310]uncertain significance1940906924090692Human1name
151839696CV1487658single nucleotide variantNM_030662.4(MAP2K2):c.1022A>C (p.Asp341Ala)Cardiovascular phenotype [RCV004043549]|RASopathy [RCV001935956]uncertain significance1940954124095412Human1name
151734118CV1494394single nucleotide variantNM_030662.4(MAP2K2):c.1087C>T (p.Leu363Phe)RASopathy [RCV001946356]uncertain significance1940944584094458Human1name
151855550CV1506749single nucleotide variantNM_030662.4(MAP2K2):c.1021G>A (p.Asp341Asn)Cardiovascular phenotype [RCV002407055]|RASopathy [RCV001937904]uncertain significance1940954134095413Human1name
155645676CV1709030single nucleotide variantNM_030662.4(MAP2K2):c.1192A>C (p.Thr398Pro)not provided [RCV002291906]uncertain significance1940906094090609Humanname
155699160CV1778817single nucleotide variantNM_030662.4(MAP2K2):c.1026C>A (p.Phe342Leu)RASopathy [RCV002299840]uncertain significance1940954084095408Human1name
9832809CV179818single nucleotide variantNM_030662.4(MAP2K2):c.1189C>T (p.Arg397Cys)RASopathy [RCV001056752]|not provided [RCV000158036]conflicting interpretations of pathogenicity|uncertain significance1940906124090612Human1name
9832808CV179819single nucleotide variantNM_030662.4(MAP2K2):c.1180A>T (p.Thr394Ser)RASopathy [RCV003654214]|not provided [RCV000158035]uncertain significance1940906214090621Human1name
9832806CV179820single nucleotide variantNM_030662.4(MAP2K2):c.1085T>C (p.Met362Thr)RASopathy [RCV000796637]|not provided [RCV001721006]likely benign|uncertain significance1940944604094460Human1name
155664285CV1855165single nucleotide variantNM_030662.4(MAP2K2):c.1117G>A (p.Glu373Lys)Cardiovascular phenotype [RCV002435121]|RASopathy [RCV003539461]|not specified [RCV004801215]uncertain significance1940906844090684Human1name
156385003CV1883648single nucleotide variantNM_030662.4(MAP2K2):c.1170C>G (p.Asn390Lys)Cardiovascular phenotype [RCV004992492]|RASopathy [RCV003093600]uncertain significance1940906314090631Human1name
156186575CV1933848single nucleotide variantNM_030662.4(MAP2K2):c.1112G>T (p.Arg371Leu)RASopathy [RCV002625219]uncertain significance1940906894090689Human1name
156324564CV1975558single nucleotide variantNM_030662.4(MAP2K2):c.1007G>A (p.Gly336Asp)RASopathy [RCV002630573]uncertain significance1940954274095427Human1name
156298689CV2017195single nucleotide variantNM_030662.4(MAP2K2):c.1073C>T (p.Ala358Val)RASopathy [RCV002715957]uncertain significance1940944724094472Human1name
156148154CV2026693single nucleotide variantNM_030662.4(MAP2K2):c.1117G>C (p.Glu373Gln)RASopathy [RCV002741137]uncertain significance1940906844090684Human1name
156204733CV2134925single nucleotide variantNM_030662.4(MAP2K2):c.1051A>C (p.Ile351Leu)RASopathy [RCV002985354]uncertain significance1940944944094494Human1name
155942430CV2143052single nucleotide variantNM_030662.4(MAP2K2):c.1196C>T (p.Ala399Val)RASopathy [RCV002994141]uncertain significance1940906054090605Human1name
11636456CV265075single nucleotide variantNM_030662.4(MAP2K2):c.1187C>T (p.Thr396Met)Cardiofaciocutaneous syndrome 4 [RCV000764203]|Noonan syndrome [RCV000824953]|RASopathy [RCV001030088]|not provided [RCV000588572]|not specified [RCV000269273]likely benign|conflicting interpretations of pathogenicity|uncertain significance1940906144090614Human3name
11641046CV269674single nucleotide variantNM_030662.4(MAP2K2):c.1064C>T (p.Ala355Val)Cardiovascular phenotype [RCV002411153]|RASopathy [RCV003539874]|not provided [RCV000725661]|not specified [RCV000349966]uncertain significance1940944814094481Human1name
401752557CV2707049single nucleotide variantNM_030662.4(MAP2K2):c.1198G>T (p.Val400Leu)Cardiofaciocutaneous syndrome 4 [RCV004723252]|Cardiovascular phenotype [RCV004321635]likely benign|uncertain significance1940906034090603Human1name
401854880CV2753349single nucleotide variantNM_030662.4(MAP2K2):c.1063G>C (p.Ala355Pro)Cardiovascular phenotype [RCV003338978]uncertain significance1940944824094482Humanname
401877062CV2793334single nucleotide variantNM_030662.4(MAP2K2):c.1120G>A (p.Val374Met)Cardiovascular phenotype [RCV004362147]uncertain significance1940906814090681Humanname
401908283CV2801325single nucleotide variantNM_030662.4(MAP2K2):c.1043A>G (p.Lys348Arg)MAP2K2-related disorder [RCV003397566]|RASopathy [RCV003655425]|not provided [RCV005235714]uncertain significance1940953914095391Human2name , trait , alternate_id
405157045CV2864785single nucleotide variantNM_030662.4(MAP2K2):c.1130T>C (p.Val377Ala)RASopathy [RCV003539526]uncertain significance1940906714090671Human1name
405165098CV2923923single nucleotide variantNM_030662.4(MAP2K2):c.1123G>T (p.Glu375Ter)RASopathy [RCV003540449]uncertain significance1940906784090678Human1name
405058030CV2983948single nucleotide variantNM_030662.4(MAP2K2):c.1105A>C (p.Ile369Leu)RASopathy [RCV003655730]uncertain significance1940906964090696Human1name
405060787CV3004095single nucleotide variantNM_030662.4(MAP2K2):c.1150T>C (p.Cys384Arg)Cardiovascular phenotype [RCV004371788]|RASopathy [RCV003655923]uncertain significance1940906514090651Human1name
405047765CV3021062single nucleotide variantNM_030662.4(MAP2K2):c.1190G>T (p.Arg397Leu)RASopathy [RCV003654507]uncertain significance1940906114090611Human1name
405048506CV3043091single nucleotide variantNM_030662.4(MAP2K2):c.1178G>T (p.Gly393Val)RASopathy [RCV003654568]uncertain significance1940906234090623Human1name
405050442CV3060401single nucleotide variantNM_030662.4(MAP2K2):c.1157C>A (p.Thr386Asn)RASopathy [RCV003654694]uncertain significance1940906444090644Human1name
405051384CV3062249single nucleotide variantNM_030662.4(MAP2K2):c.1031A>G (p.Glu344Gly)RASopathy [RCV003654767]uncertain significance1940954034095403Human1name
405052321CV3073541single nucleotide variantNM_030662.4(MAP2K2):c.1181C>T (p.Thr394Ile)RASopathy [RCV003654840]uncertain significance1940906204090620Human1name
405168574CV3122333single nucleotide variantNM_030662.4(MAP2K2):c.1085T>G (p.Met362Arg)RASopathy [RCV003818922]uncertain significance1940944604094460Human1name
405016737CV3139057single nucleotide variantNM_030662.4(MAP2K2):c.1193C>G (p.Thr398Ser)RASopathy [RCV003829394]uncertain significance1940906084090608Human1name
402475168CV3172707single nucleotide variantNM_030662.4(MAP2K2):c.1090A>G (p.Thr364Ala)RASopathy [RCV003875125]uncertain significance1940944554094455Human1name
408380690CV3523630single nucleotide variantNM_030662.4(MAP2K2):c.1001C>G (p.Pro334Arg)not provided [RCV004766028]uncertain significance1940954334095433Humanname
12740820CV360399single nucleotide variantNM_030662.4(MAP2K2):c.1039A>G (p.Asn347Asp)Cardiovascular phenotype [RCV003168601]|not specified [RCV000413213]uncertain significance1940953954095395Humanname
12740736CV360552single nucleotide variantNM_030662.4(MAP2K2):c.1036G>A (p.Val346Ile)Cardiofaciocutaneous syndrome 4 [RCV005027473]|Cardiovascular phenotype [RCV004022164]|RASopathy [RCV001861414]|not provided [RCV001718806]|not specified [RCV000412966]uncertain significance1940953984095398Human2name
597662504CV3709748single nucleotide variantNM_030662.4(MAP2K2):c.1086G>A (p.Met362Ile)Cardiofaciocutaneous syndrome 4 [RCV005028645]|RASopathy [RCV005112715]uncertain significance1940944594094459Human2name
597885792CV3774376single nucleotide variantNM_030662.4(MAP2K2):c.1079T>C (p.Leu360Pro)RASopathy [RCV005109930]uncertain significance1940944664094466Human1name
597885798CV3774377single nucleotide variantNM_030662.4(MAP2K2):c.1025T>G (p.Phe342Cys)RASopathy [RCV005109931]uncertain significance1940954094095409Human1name
597885805CV3774378single nucleotide variantNM_030662.4(MAP2K2):c.1018C>T (p.Pro340Ser)RASopathy [RCV005109932]uncertain significance1940954164095416Human1name
597933194CV3810672single nucleotide variantNM_030662.4(MAP2K2):c.1072G>A (p.Ala358Thr)RASopathy [RCV005157381]uncertain significance1940944734094473Human1name
598175019CV3890952single nucleotide variantNM_030662.4(MAP2K2):c.1049T>G (p.Leu350Arg)not provided [RCV005251805]uncertain significance1940944964094496Humanname
598196840CV3988647single nucleotide variantNM_030662.4(MAP2K2):c.1139C>T (p.Ala380Val)Cardiovascular phenotype [RCV005375333]uncertain significance1940906624090662Humanname
617154383CV4022603single nucleotide variantNM_030662.4(MAP2K2):c.1021G>T (p.Asp341Tyr)not provided [RCV005429960]uncertain significance1940954134095413Humanname
9832807CV49312single nucleotide variantNM_030662.4(MAP2K2):c.1112G>A (p.Arg371Gln)Cardiofaciocutaneous syndrome 4 [RCV005016319]|RASopathy [RCV000546588]|not provided [RCV000158034]|not specified [RCV000781515]likely benign|conflicting interpretations of pathogenicity|uncertain significance1940906894090689Human2name
9689090CV49313single nucleotide variantNM_030662.4(MAP2K2):c.1162C>T (p.Arg388Trp)Cardiofaciocutaneous syndrome 4 [RCV001334284]|Cardiovascular phenotype [RCV002354182]|Noonan syndrome [RCV000824952]|RASopathy [RCV000200611]|not provided [RCV000680296]|not specified [RCV000154509]benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance1940906394090639Human3name
14746592CV49314single nucleotide variantNM_030662.4(MAP2K2):c.1190G>A (p.Arg397His)Cardiofaciocutaneous syndrome 4 [RCV005016320]|Cardiovascular phenotype [RCV004639124]|RASopathy [RCV000813491]uncertain significance1940906114090611Human2name
14691377CV49317single nucleotide variantNM_030662.4(MAP2K2):c.1198G>A (p.Val400Met)Noonan syndrome and Noonan-related syndrome [RCV001813319]|RASopathy [RCV000866602]|not provided [RCV001610309]|not specified [RCV000781516]benign|likely benign1940906034090603Human1name
13536148CV497519single nucleotide variantNM_030662.4(MAP2K2):c.1061C>T (p.Pro354Leu)Cardiovascular phenotype [RCV003278941]|not provided [RCV002223228]|not specified [RCV000608579]uncertain significance1940944844094484Humanname
13796774CV553026insertionNM_030662.4(MAP2K2):c.1047-140_1047-139insGnot provided [RCV000680747]benign1940946374094638Humanname
13818543CV574978single nucleotide variantNM_030662.4(MAP2K2):c.1111C>T (p.Arg371Trp)Cardiofaciocutaneous syndrome 4 [RCV005027863]|Cardiovascular phenotype [RCV004025165]|RASopathy [RCV000693780]|not provided [RCV001200613]uncertain significance1940906904090690Human2name
14737146CV648136single nucleotide variantNM_030662.4(MAP2K2):c.1006G>A (p.Gly336Ser)Cardiofaciocutaneous syndrome 4 [RCV005021217]|RASopathy [RCV000803908]uncertain significance1940954284095428Human2name
14702892CV653982single nucleotide variantNM_030662.4(MAP2K2):c.1109A>G (p.Lys370Arg)Noonan syndrome [RCV000824951]uncertain significance1940906924090692Human1name
26912431CV847718single nucleotide variantNM_030662.4(MAP2K2):c.1177G>A (p.Gly393Ser)RASopathy [RCV001039331]|not specified [RCV001193485]uncertain significance1940906244090624Human1name
126728674CV985654single nucleotide variantNM_030662.4(MAP2K2):c.1019C>T (p.Pro340Leu)RASopathy [RCV005094355]|not specified [RCV001293480]uncertain significance1940954154095415Human1name
126757236CV998614single nucleotide variantNM_030662.4(MAP2K2):c.1184C>G (p.Pro395Arg)RASopathy [RCV001298822]uncertain significance1940906174090617Human1name
126767164CV998615single nucleotide variantNM_030662.4(MAP2K2):c.1163G>A (p.Arg388Gln)Cardiofaciocutaneous syndrome 4 [RCV005014367]|RASopathy [RCV001302177]|not provided [RCV004692447]uncertain significance1940906384090638Human2name
156211435CV2028430microsatelliteNM_030662.4(MAP2K2):c.151AAG[1] (p.Lys52del)RASopathy [RCV002711778]uncertain significance1941175664117568Humanname
12899956CV410614indelNM_030662.4(MAP2K2):c.919+10_919+12delinsAAGnot provided [RCV000481333]|not specified [RCV001174840]likely benign|uncertain significance1940991894099191Humanname
13626525CV533115microsatelliteNM_030662.4(MAP2K2):c.288CAT[1] (p.Ile97del)Cardiofaciocutaneous syndrome 4 [RCV002245069]|RASopathy [RCV000654959]uncertain significance1941174294117431Humanname
151879054CV1419200microsatelliteNM_030662.4(MAP2K2):c.973_974del (p.Ile325fs)Cardiofaciocutaneous syndrome 4 [RCV005016879]|RASopathy [RCV001982275]uncertain significance1940972894097290Humanname
156143179CV2163924deletionNM_030662.4(MAP2K2):c.760_761del (p.Gly254fs)RASopathy [RCV003022595]uncertain significance1940993594099360Human1name
156270169CV2178945deletionNM_030662.4(MAP2K2):c.794_824del (p.Tyr265fs)RASopathy [RCV003044425]uncertain significance1940992964099326Human1name
12912055CV248722deletionNM_030662.4(MAP2K2):c.210_212del (p.Asp71del)Smith-Magenis Syndrome-like [RCV000490823]pathogenic1941175104117512Human1name
597864278CV3767017deletionNM_030662.4(MAP2K2):c.655_658del (p.Leu219fs)RASopathy [RCV005106539]uncertain significance1941010664101069Human1name
597865208CV3861181deletionNM_030662.4(MAP2K2):c.485_492del (p.Ala162fs)RASopathy [RCV005196529]uncertain significance1941024124102419Human1name
13518208CV494977microsatelliteNM_030662.4(MAP2K2):c.860AAG[1] (p.Glu288del)Cardiovascular phenotype [RCV004024874]|RASopathy [RCV001215485]|not provided [RCV001538822]|not specified [RCV000597122]likely benign|conflicting interpretations of pathogenicity|uncertain significance1940992554099257Humanname
12901778CV410615insertionNM_030662.4(MAP2K2):c.899_900insT (p.Gly302fs)not provided [RCV000485520]uncertain significance1940992204099221Humanname
156330212CV2180931deletionNM_030662.4(MAP2K2):c.1043_1046del (p.Lys348fs)RASopathy [RCV003047164]uncertain significance1940953884095391Human1name
9832815CV49236indelNM_030662.4(MAP2K2):c.83_84delinsAA (p.Gly28Glu)RASopathy [RCV001852681]|not provided [RCV000158045]uncertain significance1941237924123793Humanname
13626522CV533117indelNM_030662.4(MAP2K2):c.191_192delinsCT (p.Val64Ala)Cardiovascular phenotype [RCV004025944]|RASopathy [RCV000654954]uncertain significance1941175304117531Humanname
405056516CV2951637indelNM_030662.4(MAP2K2):c.659_660delinsCA (p.Ile220Thr)RASopathy [RCV003655584]uncertain significance1941010644101065Humanname
405060669CV3000635indelNM_030662.4(MAP2K2):c.536_537delinsTT (p.Arg179Leu)RASopathy [RCV003655913]uncertain significance1941012724101273Humanname
14702886CV653984deletionNM_030662.4(MAP2K2):c.187_192del (p.Lys63_Val64del)Cardio-facio-cutaneous syndrome [RCV000824944]likely pathogenic1941175304117535Human1name
150436874CV1249770microsatelliteNM_030662.4(MAP2K2):c.92+229_92+230insCCCTCGGGGGAGGACGGGGCAGGGGAnot provided [RCV001665684]benign1941235544123555Humanname